Thoughts On Coca, Cannabis, Opium & Tobacco – Gifts Of The Great Spirit

Leave a comment

Holistic Terpenes & Healing Forests: The Science Behind The Entourage Effect

                     Sanrakuso at Kansho-in Temple

Are you as tired as I am of smug drug warriors who have all the research dollars locked up and then sneer that the Cannabis community can’t prove what we all know to be true because there isn’t any research? Well, now maybe there is – at least a little.

I’ll wait for others to voice their thoughts, but I’m thinking the research we’ll cover in this post means no more “You can’t prove it” bullshit about the Cannabis Entourage Effect from Pig Pharma & their federal shills.

The studies cited throughout this blog post reference terpenes and other phytochemicals found in the natural emissions and vapors of “Forest Bath” environments and prove their wide-ranging efficacy as inhaled and absorbed therapeutic & healing agents.

(Please see my previous post for a full discussion of “Forest Bathing” and Cannabis.)

The “Forest Bath” research also shows clearly that the healing potential of this class of phytochemicals is far from fully understood.

These same “Forest Bath” terpenes and other phytochemicals, exactly the same ones, are found in Cannabis emissions and vapors, in almost the same proportions, and they vary among Cannabis strains the same way that emissions from tree species vary among Healing Forests.

Hundreds of peer-reviewed scientific and medical research studies support the therapeutic validity of the ancient practice of Forest Bathing. Perhaps this same body of science, properly interpreted, would allow the Cannabis community to checkmate the anti-Cannabis propagandists and their scientific pretensions with some solid, relevant data. The planet is tight.

A Little Background

The totality of “Forest Bath” research provides precisely the range of scientific experimental evidence needed to validate ancient Cannabis wisdom and provide strong data-based support for the healing powers of the Cannabis “Entourage Effect”.

South Korean scientists and public health researchers have documented a wide range of positive health benefits from exposure to terpenes in the air of coniferous forests. They have established that variations among the emitted terpenes of different species of trees create highly diverse, differently beneficial micro-environments.

South Korean, Japanese & Taiwanese healing forests are all well mapped – this tall forested mountain valley for asthma; that craggy seaside forest for dermatitis. These healing forests have been well-known for hundreds of generations, and thousands of ancient shrines celebrate the spiritual qualities & health benefits of forested environments throughout Northeast Asia. Legends are filled with heroes suffering grievous battle wounds going alone into the forests and emerging weeks later miraculously healed.

Forest Bath research shows that the dominant terpenes in the air of the most highly-rated “healthy forests” are the same terpenes, primarily a-pinene, myrcene, linalool, and d-limonene, that dominate and differentiate the aromas, tastes and effects of various Cannabis strains.

Because inhaling both Forest terpenes and Cannabis terpenes involves inhaling virtually the same phytochemical mix, “Forest Bath” research pretty well refutes those smug anti-Cannabis arguments against the “Entourage Effect” that boil down to “You can’t prove it because there’s no research”.

Until now, we’ve been limited to a justifiably angry “Of course there isn’t any research you assholes – you’ll have anyone who tries to do the damn research arrested!” Which of course immediately provokes: “Well, that Cannabis certainly does make you people touchy,” followed by further self-satisfied smirks.  

Maybe Forest Bath research changes the balance of smirk-entitlement.

Forest Bath research provides a thoroughly validated database in support of the health benefits of inhaling the precise aerosolized natural terpenes involved in the Cannabis “Entourage Effect”, clearly establishing the link between inhaling a natural blend of specific aerosolized or vaporized terpenes and associated phytochemicals and obtaining cumulative, lasting, measurable health benefits..

Some of the research references that follow this introduction focus on studying the biological activity of a single terpene in a laboratory environment, such as a-pinene’s effect on cardiac cell inflammation in vitro, while others focus on measuring variables like blood pressure in people exposed to natural forest environments under experimental conditions. Taken as a whole they form a good platform for launching further Cannabis “Entourage Effect” research even in the presence of the Federal war on Citizens.

Note of caution in applying Forest Bath research to Cannabis:

When we’re looking at the science behind “Forest Bathing” to inform our understanding of inhaling/ingesting Cannabis terpenes, it’s important to differentiate between the terpene/phytochemical content of the smoke stream of combusted Cannabis and the terpene/phytochemical content of the vapors emitted under various conditions by the whole, non-combusted but “vaporized” Cannabis flower.

A combustion smoke stream contains both the byproducts of combustion itself, including particles of toxic soot, and vaporized organic compounds including THC and all the cannabinoids, terpenoids, flavonoids and other phytochemicals. These compounds are heated to the point of “boiling off” the plant materials ahead of advancing combustion, and those that are especially vulnerable to heat are partially degraded by that process.

On the other hand, dry distillation of Cannabis flowers, also called vaporizing, does not create combustion byproducts in the vapor stream – no toxic soot- because the heating process leading to the change of state from resin to vapor is non-destructive. Nothing burns. The terpene profile in a vapor stream is close to the natural profile of the terpenes in the whole flower before vaporizing occurs because even the most heat-sensitive Cannabis flower phytochemicals survive well-calibrated vaporizing, while far fewer survive even the gentlest combustion.

That difference may be medically significant. It seems likely that the “Forest Bath” science applies directly to an “Entourage Effect” from vaporized Cannabis flowers but somewhat less to combusted flowers.

In other words, inhaling Cannabis vapor is more like taking a pleasant walk through a forest, and inhaling Cannabis smoke is more like being in front of a nice campfire. Both excellent experiences; each very different.

So I’m suggesting that “Entourage Effect” discussions focus more on the health and sensual benefits of inhaling the natural emissions and vapors of Cannabis, as well as ingestion of the natural Cannabis flower by other means, and maybe focus a little less on inhaling Cannabis smoke which has the same toxic effects as inhaling any smoke regardless of benefits, and can’t be dismissed as a serious health hazard.

The following “Forest Bath” research literature citations, all from peer-reviewed scientific journals, are all curated in the US National Institutes of Health “PubMed” database. This provenance means that anti-Cannabis “scientists” cannot challenge the validity of the large body of “Forest Bath” research, nor its applicability to Cannabis and the “Entourage Effect”.

So, if you want to dig deeper into the science, here are the results of the “Forest Bathing” literature research brilliantly elucidated by the Korean Society of Toxicology team. I’ve added revised PubMed links to the original citations and edited a bit for clarity where I thought it was needed:

Therapeutic Potential Of Inhaled Conifer Forest Terpenes


“ α-Pinene, found in oils of coniferous trees and rosemary, showed anti-inflammatory activity by decreasing the activity of mitogen-activated protein kinases (MAPKs), expression of nuclear factor kappa B (NF-κB), and production of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and nitric oxide (NO) in lipopolysaccharide (LPS)-induced macrophages (link to original research).”

“In ovalbumin-sensitized mouse model of allergic rhinitis, pretreatment with α-pinene decreased clinical symptoms and levels of immunoglobulin E and IL-4 (link to original research).”

“In human chondrocytes, α-pinene inhibited IL-1β-induced inflammation pathway by suppressing NF-κB, c-Jun N-terminal kinase (JNK) activation, and expression of iNOS and matrix metalloproteinases (MMP)-1 and -13, suggesting its role as an anti-osteoarthritic agent (link to original research).”

“Strong anti-inflammatory activity was observed when α-pinene was used in combination with two active ingredients of frankincense, linalool and 1-octanol (link to original research).”

“The Anti-tumor effects of pinenes are well established on tumor lymphocytes as well as tumor cell lines (link to original research).”

“Matsuo et al. (link to original research) identified proapoptotic and anti-metastatic activities of α-pinene in a melanoma model.”

“Later, it was revealed in human hepatoma Bel-7402 cells that the proapoptotic effect of α-pinene is associated with induction of G2/M cell cycle arrest (link to original research).”

“In addition, α-pinene triggers oxidative stress signaling pathways in A549 and HepG2 cells (link to original research).”

“Kusuhara et al. (link to original research) reported that mice kept in a setting enriched with α-pinene showed reduction in melanoma sizes, while in vitro treatment of melanoma cells with α-pinene had no inhibitory effect on cell proliferation, suggesting that the in vivo result may not be due to a direct effect of α-pinene.”

“Investigation of β-pinene also revealed its cytotoxic activity against cancer and normal cell lines with a more pronounced effect on neoplastic cells in the majority of cases, showing acceptable chemotherapeutic potency (citation #1,citation #2).”

“α-pinene and 1, 8-cineole also exert neuroprotective effects by regulating gene expression. They protected PC12 cells against oxidative stress-induced apoptosis through ROS scavenging and induction of nuclear Nrf2 factor followed by enhanced expression of antioxidant enzymes including catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, and HO-1 (link to original research).”


“Myrcene, the acyclic monoterpene, also exhibits significant antiproliferative and cytotoxic effects in various tumor cell lines such as MCF-7 (breast carcinoma), HeLa (human cervical carcinoma), A549 (human lung carcinoma), HT-29 (human colon adenocarcinoma), P388 (leukemia), and Vero (monkey kidney) as well as mouse macrophages (citation #1,citation #2).”

“Essential oil from Vepris macrophylla demonstrated a strong cytotoxic effect, suggesting that the effect may be attributed to the presence of specific components, among which is myrcene (link to original research).”


“Treatment with linalool, a natural compound found in essential oils of aromatic plants, inhibited cigarette smoke-induced acute lung inflammation by inhibiting infiltration of inflammatory cells and production of TNF-α, IL-6, IL-1β, IL-8, and monocyte chemoattractant protein – 1 (MCP-1), as well as NF-κB activation (link to original research).”

“In another lung injury model, linalool attenuated lung histopathologic changes in LPS-induced mice. In in vitro experiments, linalool reduced production of TNF-α and IL-6 and blocked phosphorylation of IκBα protein, p38, and JNK in LPS-stimulated RAW 264.7 macrophages (link to original research).”

“Similarly, linalool inhibited production of TNF-α, IL-1β, NO, and PGE2 in LPS-stimulated microglia cells (link to original research).”

“Li et al. (link to original research) showed that the anti-inflammatory effect of linalool is involved in activation of Nrf2/heme oxygenase-1 (HO-1) signaling pathway.”

“Frankincense oil extract, which contains linalool, exhibited anti-inflammatory and analgesic effects in a xylene-induced ear edema model and a formalin-inflamed hind paw model by inhibiting COX-2 (link to original research).”


“The anti-tumorigenic activity of d-limonene is well-established. Numerous studies have demonstrated the protective effects of d-limonene against chemical-induced tumors in various tissue types such as breast, intestine, pancreas, liver, and colon (citation #1citation #2).”

 “Another naturally occurring monoterpene d-limonene was reported to reduce allergic lung inflammation in mice probably via its antioxidant properties (link to original research).”

“It also reduced carrageenan-induced inflammation by reducing cell migration, cytokine production, and protein extravasation (link to original research).”

“Similar to α-pinene, d-limonene exerted an anti-osteoarthritic effect by inhibiting IL-1β-induced NO production in human chondrocytes (link to original research).”

“d-Limonene treatment reduced doxorubicin-induced production of two proinflammatory cytokines, TNF-α and prostaglandin E-2 (PGE2) (link to original research).”

 “Lu et al. (link to original research) revealed that d-limonene could inhibit the proliferation of human gastric cancer cells by inducing apoptosis.”

“Later, it was demonstrated that apoptosis of tumor cells by d-limonene could be mediated by the mitochondrial death pathway via activated caspases and PARP cleavage as well as by the suppression of the PI3K/Akt pathway (citation #1,citation #2).”


“Monoterpene p-cymene treatment reduced elastase-induced lung emphysema and inflammation in mice. It reduced the alveolar enlargement, number of macrophages, and levels of proinflammatory cytokines such as IL-1β, IL-6, IL-8, and IL-17 in bronchoalveolar lavage fluid (BALF) (link to original research).”

“Similarly, p-cymene showed a protective effect in a mouse model of LPS-induced acute lung injury by reducing the number of inflammatory cells in the BALF and expression of NF-κB in the lungs (link to original research) and by reducing production of proinflammatory cytokines and infiltration of inflammatory cells (link to original research).”

“Mechanistically, p-cymene blocks NF-κB and MAPK signaling pathways. It has been reported that p-cymene reduces production of TNF-α, IL-6, and IL-β in LPS-treated RAW 264.7 macrophages. In C57BL/6 mice, TNF-α and IL-1β were downregulated and IL-10 was upregulated by p-cymene treatment. It also inhibited LPS-induced activation of ERK 1/2, p38, JNK, and IκBα (citation #1,citation #2).”

“p-Cymene has been reported to have cytotoxic effects on tumor cell lines (link to original research).”

“Recently, Li et al. (link to original research) evaluated beneficial effects of p-cymene on in vitro TPA-augmented invasiveness of HT-1080 cells, and found that it inhibits MMP-9 expression, but enhances TIMP-1 production along with the suppression of ERK1/2 and p38 MAPK signal pathways in tumor cells, suggesting that p-cymene is an effective candidate for the prevention of tumor invasion and metastasis.”


“The monoterpene γ-terpinene, present in the essential oil of many plants including Eucalyptus, reduced the acute inflammatory response. It reduced carrageenan-induced paw edema, migration of neutrophil into lung tissue, and IL-1β and TNF-α production and inhibited fluid extravasation (link to original research).”

“Terpinene-containing essential oil from Liquidambar formosana leaves reduced inflammatory response in LPS-stimulated mouse macrophages by reducing reactive oxygen species (ROS), JNK, ERK, p38 MAP kinase, and NF-κB (link to original research).”

“Another terpinene-containing essential oil from Citrus unshiu flower or fingered citron (C. medica L. var. sarcodactylis) reduced LPS-stimulated PGE2 and NO production in RAW 264.7 cells. Furthermore, production of inflammatory cytokines, such as IL-1β, TNF-α, and IL-6, was also reduced in macrophages (citation #1,citation #2).”


“Borneol, a bicyclic monoterpene present in Artemisia, Blumea, and Kaempferia, has been used in traditional medicine. Borneol alleviated acute lung inflammation by reducing inflammatory infiltration, histopathological changes, and cytokine production in LPS-stimulated mice. It suppressed phosphorylation of NF-κB, IκBα, p38, JNK, and ERK (link to original research).”

“Oral administration and intrathecal injection of borneol showed antihyperalgesic effects on inflammatory pain in complete Freund’s adjuvant-induced hypersensitive animal models by enhancing GABAAR (Gamma-Aminobutyric Acid Type A Receptor)-mediated GABAergic transmission (link to original research).”

“Borneol inhibited migration of leukocytes into the peritoneal cavity in carrageenan-stimulated mice, suggesting its anti-inflammatory function (link to original research).”

“In addition, borneol inhibited TRPA1, a cation channel that is involved in inflammation and noxious-pain sensing, suggesting that its use as an anti-inflammatory agent for neuropathic-pain and trigeminal neuralgia (link to original research).”

“Previous studies showed that borneol has free radical scavenging activity (link to original research) and is a major component of essential oil of SuHeXiang Wan (link to original research) whose neuroprotective function has been reported in in vivo and in vitro models of Alzheimer’s disease (AD) (citation #1,citation #2).”

“Moreover, a recent study showed that borneol exerts a neuroprotective effect against β-amyloid (Aβ) cytotoxicity via upregulation of nuclear translocation of Nrf2 and expression of Bcl-2 (link to original research).”

“In addition, treatment with isoborneol, a monoterpenoid alcohol, significantly reduced 6-hydroxydopamine-induced ROS generation and cell death in human neuroblastoma SH-SY5Y cells, suggesting that isoborneol may be a potential therapeutic agent for treatment of neurodegenerative diseases associated with oxidative stress (link to original research).”


“α-Caryophyllene, known as humulene, is a naturally occurring monocyclic sesquiterpene. BCP, an isomer of α-caryophyllene, has been identified as an active component of an essential oil mixture that not only prevents solid tumor growth and proliferation of cancer cell lines but also inhibits lymph node metastasis of melanoma cells in high-fat diet-induced obese mice (citation #1,citation #2).”

“Sarvmeili et al. (link to original research) reported that Pinus eldarica essential oil, of which BCP was the major component, exerts cytotoxic effects on HeLa and MCF-7 cell lines.”

“β-caryophyllene (BCP) was reported to protect against neuroinflammation in a rat model of Parkinson’s disease (PD) by attenuating production of proinflammatory cytokines and inflammatory mediators such as COX-2 and iNOS (link to original research).”

“Chronic treatment with BCP attenuated alcohol-induced liver injury and inflammation by reducing the proinflammatory phenotypic switch of hepatic macrophages and neutrophil infiltration. The beneficial effects of BCP on liver injury are mediated by cannabinoid 2 (CB2) receptor activation (link to link to original research).”

“Prolonged administration of BCP reduced proinflammatory cytokines in pancreatic tissue of streptozotocin-induced diabetic rats (link to original research).”

“BCP reduced expression of Toll-like receptor 4 and macrophage inflammatory protein-2, and phosphorylation of ERK, p38, JNK, and NF-κB in D-galactosamine and LPS-induced liver injury mouse model (link to original research).”

“BCP has antioxidant effects (link to original research), and functions as a regulator of several neuronal receptors and shows various pharmacological activities including neuroprotection (link to original research).”

“Neuroprotective effects of BCP have been reported in both AD and PD animal models. Oral treatment with BCP prevented AD-like phenotype such as cognitive impairment and activation of inflammation through CB2 receptor activation and the PPARγ pathway (link to original research).”


No more “You can’t prove it” bullshit. The studies cited throughout this post reference terpenes and other phytochemicals found in natural emissions and vapors of “Forest Bath” environments. These same terpenes and other phytochemicals, exactly the same, are found in Cannabis emissions and vapors, in almost the same proportions, and vary between Cannabis strains the same way that emissions from tree species vary among Healing Forests. I hope that the connection between hundreds of peer-reviewed scientific and medical research studies that support the ancient practice of Forest Bathing and their direct applicability to the  Entourage Effect will allow the Cannabis community to finally checkmate the anti-Cannabis propagandists and their scientific pretensions.


  1. Frumkin H. Beyond toxicity: human health and the natural environment. Am J Prev Med. 2001;20:234–240. doi: 10.1016/S0749-3797(00)00317-2. PubMed    

  2. Tsunetsugu Y, Park BJ, Miyazaki Y. Trends in research related to “Shinrin-yoku” (taking in the forest atmosphere or forest bathing) in Japan. Environ Health Prev Med. 2010;15:27–37. doi: 10.1007/s12199-009-0091-z. PMC free article  PubMed  

  3. Seo SC, Park SJ, Park CW, Yoon WS, Choung JT, Yoo Y. Clinical and immunological effects of a forest trip in children with asthma and atopic dermatitis. Iran J Allergy Asthma Immunol. 2015;14:28–36. PubMed

  4. Douglass RW. Forest recreation. 3rd edition. Pergamon Press; 1982.

  5. Spievogel I, Spalek K. Medicinal plants uesed in pediatric prophylactic method of Sebastian Kneipp. Nat J. 2012;45:9–18.

  6. Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany: a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006;6:19. doi: 10.1186/1472-6882-6-19. PMC free article  PubMed  

  7. Park BJ, Tsunetsugu Y, Kasetani T, Kagawa T, Miyazaki Y. The physiological effects of Shinrin-yoku (taking in the forest atmosphere or forest bathing): evidence from field experiments in 24 forests across Japan. Environ Health Prev Med. 2010;15:18–26. doi: 10.1007/s12199-009-0086-9. PMC free article  PubMed  

  8. Song C, Ikei H, Miyazaki Y. Physiological effects of nature therapy: A review of the research in Japan. Int J Environ Res Public Health. 2016;13:E781. doi: 10.3390/ijerph13080781. PMC free article  PubMed  

  9. Gershenzon J, Dudareva N. The function of terpene natural products in the natural world. Nat Chem Biol. 2007;3:408–414. doi: 10.1038/nchembio.2007.5. PubMed

  10. Chappell J. The genetics and molecular genetics of terpene and sterol origami. Curr Opin Plant Biol. 2002;5:151–157. doi: 10.1016/S1369-5266(02)00241-8. PubMed

  11. Mewalal R, Rai DK, Kainer D, Chen F, Külheim C, Peter GF, Tuskan GA. Plant-derived terpenes: A feedstock for specialty biofuels. Trends Biotechnol. 2016 S0167-7799(16)30128-7. PubMed

  12. Kirby J, Keasling JD. Biosynthesis of plant isoprenoids: perspectives for microbial engineering. Annu Rev Plant Biol. 2009;60:335–355. doi: 10.1146/annurev.arplant.043008.091955. PubMed

  13. Zulak KG, Bohlmann J. Terpenoid biosynthesis and specialized vascular cells of conifer defense. J Integr Plant Biol. 2010;52:86–97. doi: 10.1111/j.1744-7909.2010.00910.x. PubMed

  14. Lange BM, Ahkami A. Metabolic engineering of plant monoterpenes, sesquiterpenes and diterpenes: current status and future opportunities. Plant Biotechnol J. 2013;11:169–196. doi: 10.1111/pbi.12022. PubMed

  15. Dubey VS, Bhalla R, Luthra R. An overview of the non-mevalonate pathway for terpenoid biosynthesis in plants. J Biosci. 2003;28:637–646. doi: 10.1007/BF02703339. PubMed

  16. Matsuba Y, Nguyen TT, Wiegert K, Falara V, Gonzales-Vigil E, Leong B, Schäfer P, Kudrna D, Wing RA, Bolger AM, Usadel B, Tissier A, Fernie AR, Barry CS, Pichersky E. Evolution of a complex locus for terpene biosynthesis in solanum. Plant Cell. 2013;25:2022–2036. doi: 10.1105/tpc.113.111013. PMC free article  PubMed  

  17. Martin DM, Gershenzon J, Bohlmann J. Induction of volatile terpene biosynthesis and diurnal emission by methyl jasmonate in foliage of Norway spruce. Plant Physiol. 2003;132:1586–1599. doi: 10.1104/pp.103.021196. PMC free article  PubMed  

  18. Lee DH, Kim MH, Park OH, Park KS, An SS, Seo HJ, Jin SH, Jeong WS, Kang YJ, An KW, Kim ES. A study on the distribution characteristics of terpene at the main trails of Mt. Mudeung. J Environ Health Sci. 2013;39:211–222. doi: 10.1080/10934529.2012.717818.

  19. Rufino AT, Ribeiro M, Judas F, Salgueiro L, Lopes MC, Cavaleiro C, Mendes AF. Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity. J Nat Prod. 2014;77:264–269. doi: 10.1021/np400828x. PubMed

  20. Ma J, Xu H, Wu J, Qu C, Sun F, Xu S. Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation. Int Immunopharmacol. 2015;29:708–713. doi: 10.1016/j.intimp.2015.09.005. PubMed

  21. Rodrigues KA, Amorim LV, Dias CN, Moraes DFC, Carneiro SM, Carvalho FA. Syzygium cumini (L.) Skeels essential oil and its major constituent α-pinene exhibit anti-Leishmania activity through immunomodulation in vitro. J Ethnopharmacol. 2015;160:32–40. doi: 10.1016/j.jep.2014.11.024. PubMed

  22. Li XJ, Yang YJ, Li YS, Zhang WK, Tang HB. α-Pinene, linalool and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2. J Ethnopharmacol. 2016;179:22–26. doi: 10.1016/j.jep.2015.12.039. PubMed

  23. Yu PJ, Wan LM, Wan SH, Chen WY, Xie H, Meng DM, Zhang JJ, Xiao XL. Standardized myrtol attenuates lipopolysaccharide induced acute lung injury in mice. Pharm Biol. 2016;54:3211–3216. doi: 10.1080/13880209.2016.1216132. PubMed

  24. Kim DS, Lee HJ, Jeon YD, Han YH, Kee JY, Kim HJ, Shin HJ, Kang J, Lee BS, Kim SH, Kim SJ, Park SH, Choi BM, Park SJ, Um JY, Hong SH. Alpha-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages. Am J Chin Med. 2015;43:731–742. doi: 10.1142/S0192415X15500457. PubMed

  25. Nam SY, Chung Ck, Seo JH, Rah SY, Kim HM, Jeong HJ. The therapeutic efficacy of α-pinene in an experimental mouse model of allergic rhinitis. Int Immunopharmacol. 2014;23:273–282. doi: 10.1016/j.intimp.2014.09.010. PubMed

  26. Hansen JS, Nørgaard AW, Koponen IK, Sørli JB, Paidi MD, Hansen SW, Clausen PA, Nielsen GD, Wolkoff P, Larsen ST. Limonene and its ozone-initiated reaction products attenuate allergic lung inflammation in mice. J Immunotoxicol. 2016;13:793–803. doi: 10.1080/1547691X.2016.1195462. PubMed

  27. Amorim JL, Simas DLR, Pinheiro MM, Moreno DS, Alviano CS, da Silva AJ, Fernandes PD. Antiinflammatory properties and chemical characterization of the essential oils of four citrus species. PLoS ONE. 2016;11:e0153643. doi: 10.1371/journal.pone.0153643. PMC free article  PubMed

  28. Rufino AT, Ribeiro M, Sousa C, Judas F, Salgueiro L, Cavaleiro C, Mendes AF. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur J Pharmacol. 2015;750:141–150. doi: 10.1016/j.ejphar.2015.01.018. PubMed

  29. Rehman MU, Tahir M, Khan AQ, Khan R, Oday-O-Hamiza, Lateef A, Hassan SK, Rashid S, Ali N, Zeeshan M, Sultana S. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS and NFκB in kidneys of Wistar rats. Exp Biol Med (Maywood) 2014;239:465–476. doi: 10.1177/1535370213520112. PubMed

  30. Games E, Guerreiro M, Santana FR, Pinheiro NM, de Oliveira EA, Lopes FD, Olivo CR, Tibério IF, Martins MA, Lago JH, Prado CM. Structurally related monoterpenes p-Cymene, carvacrol and thymol isolated from essential oil from leaves of lippia sidoides cham. (Verbenaceae) protect mice against elastase-induced emphysema. Molecules. 2016;21:E1390. doi: 10.3390/molecules21101390. PubMed

  31. Chen L, Zhao L, Zhang C, Lan Z. Protective effect of p-cymene on lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2014;37:358–364. doi: 10.1007/s10753-013-9747-3. PubMed

  32. Xie G, Chen N, Soromou LW, Liu F, Xiong Y, Wu Q, Li H, Feng H, Liu G. p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules. 2012;17:8159–8173. doi: 10.3390/molecules17078159. PubMed    

  33. Zhong W, Chi G, Jiang L, Soromou LW, Chen N, Huo M, Guo W, Deng X, Feng H. p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation. 2013;36:529–537. doi: 10.1007/s10753-012-9574-y. PubMed    

  34. Huo M, Cui X, Xue J, Chi G, Gao R, Deng X, Guan S, Wei J, Soromou LW, Feng H, Wang D. Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model. J Surg Res. 2013;180:e47–e54. doi: 10.1016/j.jss.2012.10.050. PubMed    

  35. Li Y, Lv O, Zhou F, Li Q, Wu Z, Zheng Y. Linalool inhibits LPS-induced inflammation in BV2 microglia cells by activating Nrf2. Neurochem Res. 2015;40:1520–1525. doi: 10.1007/s11064-015-1629-7. PubMed    

  36. de Oliveira Ramalho TR, de Oliveira MT, de Araujo Lima AL, Bezerra-Santos CR, Piuvezam MR. Gamma-terpinene modulates acute inflammatory response in mice. Planta Med. 2015;81:1248–1254. doi: 10.1055/s-0035-1546169. PubMed    

  37. Hua KF, Yang TJ, Chiu HW, Ho CL. Essential oil from leaves of Liquidambar formosana ameliorates inflammatory response in lipopolysaccharide-activated mouse macrophages. Nat Prod Commun. 2014;9:869–872. PubMed

  38. Kim KN, Ko YJ, Yang HM, Ham YM, Roh SW, Jeon YJ, Ahn G, Kang MC, Yoon WJ, Kim D, Oda T. Anti-inflammatory effect of essential oil and its constituents from fingered citron (Citrus medica L. var. sarcodactylis) through blocking JNK, ERK and NF-κB signaling pathways in LPS-activated RAW 264.7 cells. Food Chem Toxicol. 2013;57:126–131. doi: 10.1016/j.fct.2013.03.017. PubMed    

  39. Kim MJ, Yang KW, Kim SS, Park SM, Park KJ, Kim KS, Choi YH, Cho KK, Hyun CG. Chemical composition and anti-inflammation activity of essential oils from Citrus unshiu flower. Nat Prod Commun. 2014;9:727–730. PubMed

  40. Zhong W, Cui Y, Yu Q, Xie X, Liu Y, Wei M, Ci X, Peng L. Modulation of LPS-stimulated pulmonary inflammation by borneol in murine acute lung injury model. Inflammation. 2014;37:1148–1157. doi: 10.1007/s10753-014-9839-8. PubMed    

  41. Jiang J, Shen YY, Li J, Lin YH, Luo CX, Zhu DY. (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. Eur J Pharmacol. 2015;757:53–58. doi: 10.1016/j.ejphar.2015.03.056. PubMed    

  42. Almeida JR, Souza GR, Silva JC, Saraiva SR, Júnior RG, Quintans Jde S, Barreto Rde S, Bonjardim LR, Cavalcanti SC, Quintans LJ., Jr Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice. ScientificWorldJournal. 2013;2013:808460. doi: 10.1155/2013/808460. PMC free article  PubMed     

  43. Sherkheli MA, Schreiner B, Haq R, Werner M, Hatt H. Borneol inhibits TRPA1, a proinflammatory and noxious pain-sensing cation channel. Pak J Pharm Sci. 2015;28:1357–1363. PubMed

  44. Ojha S, Javed H, Azimullah S, Haque ME. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation and salvages dopaminergic neurons in a rat model of Parkinson disease. Mol Cell Biochem. 2016;418:59–70. doi: 10.1007/s11010-016-2733-y. PubMed    

  45. Varga ZV, Matyas C, Erdelyi K, Cinar R, Nieri D, Chicca A, Nemeth BT, Paloczi J, Lajtos T, Corey L, Hasko G, Gao B, Kunos G, Gertsch J, Pacher P. Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. Br J Pharmacol. 2017 doi: 10.1111/bph.13722. PubMed    

  46. Basha RH, Sankaranarayanan C. β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem Biol Interact. 2016;245:50–58. doi: 10.1016/j.cbi.2015.12.019. PubMed    

  47. Cho HI, Hong JM, Choi JW, Choi HS, Kwak JH, Lee DU, Lee SK, Lee SM. β-Caryophyllene alleviates d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. Eur J Pharmacol. 2015;764:613–621. doi: 10.1016/j.ejphar.2015.08.001. PubMed    

  48. Kim MJ, Yang KW, Kim SS, Park SM, Park KJ, Kim KS, Choi YH, Cho KK, Lee NH, Hyun CG. Chemical composition and anti-inflammatory effects of essential oil from Hallabong flower. EXCLI J. 2013;12:933–942. PMC free article  PubMed

  49. Chaiyana W, Anuchapreeda S, Leelapornpisid P, Phongpradist R, Viernstein H, Mueller M. Development of microemulsion delivery system of essential oil from Zingiber cassumunar Roxb. Rhizome for improvement of stability and anti-inflammatory activity. AAPS PharmSciTech. 2016:1–11. PubMed

  50. Yang H, Zhao R, Chen H, Jia P, Bao L, Tang H. Bornyl acetate has an anti-inflammatory effect in human chondrocytes via induction of IL-11. IUBMB Life. 2014;66:854–859. doi: 10.1002/iub.1338. PubMed    

  51. Sobral MV, Xavier AL, Lima TC, de Sousa DP. Antitumor activity of monoterpenes found in essential oils. Scientific World Journal. 2014;2014:953451. doi: 10.1155/2014/953451. PMC free article  PubMed     

  52. Broitman SA, Wilkinson J, 4th, Cerda S, Branch SK. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic “Metastases” in vitro. Adv Exp Med Biol. 1996;401:111–130. doi: 10.1007/978-1-4613-0399-2_9. PubMed    

  53. Uedo N, Tatsuta M, Iishi H, Baba M, Sakai N, Yano H, Otani T. Inhibition by d-limonene of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett. 1999;137:131–136. doi: 10.1016/S0304-3835(98)00340-1. PubMed    

  54. Stratton S, Dorr R, Alberts D. The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer. 2000;36:1292–1297. doi: 10.1016/S0959-8049(00)00108-8. PubMed    

  55. Kaji I, Tatsuta M, Iishi H, Baba M, Inoue A, Kasugai H. Inhibition by D-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21ras plasma membrane association. Int J Cancer. 2001;93:441–444. doi: 10.1002/ijc.1353. PubMed    

  56. Guyton KZ, Kensler TW. Prevention of liver cancer. Curr Oncol Rep. 2002;4:464–470. doi: 10.1007/s11912-002-0057-4. PubMed    

  57. Lu XG, Zhan LB, Feng BA, Qu MY, Yu LH, Xie JH. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J Gastroenterol. 2004;10:2140–2144. doi: 10.3748/wjg.v10.i14.2140. PMC free article  PubMed     

  58. Ji J, Zhang L, Wu YY, Zhu XY, Lv SQ, Sun XZ. Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. Leuk Lymphoma. 2006;47:2617–2624. doi: 10.1080/00268970600909205. PubMed    

  59. Jia SS, Xi GP, Zhang M, Chen YB, Lei B, Dong XS, Yang YM. Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells. Oncol Rep. 2013;29:349–354. PubMed

  60. Li Q. Effect of forest bathing trips on human immune function. Environ Health Prev Med. 2010;15:9–17. doi: 10.1007/s12199-008-0068-3. PMC free article  PubMed     

  61. Bansal A, Moriarity DM, Takaku S, Setzer WN. Chemical composition and cytotoxic activity of the leaf essential oil of Ocotea tonduzii from Monteverde, Costa Rica. Nat Prod Commun. 2007;2:781–784.

  62. Matsuo AL, Figueiredo CR, Arruda DC, Pereira FV, Scutti JA, Massaoka MH, Travassos LR, Sartorelli P, Lago JH. α-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoptosis and confers antimetastatic protection in a melanoma model. Biochem Biophys Res Commun. 2011;411:449–454. doi: 10.1016/j.bbrc.2011.06.176. PubMed    

  63. Chen W, Liu Y, Li M, Mao J, Zhang L, Huang R, Jin X, Ye L. Anti-tumor effect of α-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest. J Pharmacol Sci. 2015;127:332–338. doi: 10.1016/j.jphs.2015.01.008. PubMed    

  64. Jin KS, Bak MJ, Jun M, Lim HJ, Jo WK, Jeong WS. α-Pinene triggers oxidative stress and related signaling pathways in A549 and HepG2 cells. Food Sci Biotechnol. 2010;19:1325–1332. doi: 10.1007/s10068-010-0189-5.  

  65. Kusuhara M, Urakami K, Masuda Y, Zangiacomi V, Ishii H, Tai S, Maruyama K, Yamaguchi K. Fragrant environment with α-pinene decreases tumor growth in mice. Biomed Res. 2012;33:57–61. doi: 10.2220/biomedres.33.57. PubMed    

  66. Bakarnga-Via I, Hzounda JB, Fokou PVT, Tchokouaha LRY, Gary-Bobo M, Gallud A, Garcia M, Walbadet L, Secka Y, Dongmo PMJ, Boyom FF, Menut C. Composition and cytotoxic activity of essential oils from Xylopia aethiopica (Dunal) A. Rich, Xylopia parviflora (A. Rich) Benth. and Monodora myristica (Gaertn) growing in chad and cameroon. BMC Complement Altern Med. 2014;14:125. doi: 10.1186/1472-6882-14-125. PMC free article  PubMed     

  67. Li YL, Yeung CM, Chiu L, Cen YZ, Ooi VE. Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla. Phytother Res. 2009;23:140–142. doi: 10.1002/ptr.2567. PubMed    

  68. Meadows SM, Mulkerin D, Berlin J, Bailey H, Kolesar J, Warren D, Thomas JP. Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. Int J Gastrointest Cancer. 2002;32:125–128. doi: 10.1385/IJGC:32:2-3:125. PubMed    

  69. Chen TC, Cho HY, Wang W, Wetzel SJ, Singh A, Nguyen J, Hofman FM, Schönthal AH. Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo. J Biomed Sci. 2015;22:71. doi: 10.1186/s12929-015-0175-6. PMC free article  PubMed     

  70. Bardon S, Foussard V, Fournel S, Loubat A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett. 2002;181:187–194. doi: 10.1016/S0304-3835(02)00047-2. PubMed    

  71. Yeruva L, Pierre KJ, Elegbede A, Wang RC, Carper SW. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett. 2007;257:216–226. doi: 10.1016/j.canlet.2007.07.020. PubMed    

  72. Ferraz RP, Bomfim DS, Carvalho NC, Soares MB, da Silva TB, Machado WJ, Prata APN, Costa EV, Moraes VRS, Nogueira PCL, Bezerra DP. Cytotoxic effect of leaf essential oil of Lippia gracilis Schauer (Verbenaceae) Phytomedicine. 2013;20:615–621. doi: 10.1016/j.phymed.2013.01.015. PubMed    

  73. Li J, Liu C, Sato T. Novel antitumor invasive actions of p-Cymene by decreasing MMP-9/TIMP-1 expression ratio in human fibrosarcoma HT-1080 cells. Biol Pharm Bull. 2016;39:1247–1253. doi: 10.1248/bpb.b15-00827. PubMed    

  74. Saleh M, Hashem F, Glombitza K. Cytotoxicity and in vitro effects on human cancer cell lines of volatiles of Apium graveolens var filicinum. Pharm Pharmacol Lett. 1998;8:97–99.

  75. Silva SLD, Figueiredo PM, Yano T. Cytotoxic evaluation of essential oil from Zanthoxylum rhoifolium Lam. leaves. Acta Amaz. 2007;37:281–286. doi: 10.1590/S0044-59672007000200015.  

  76. Maggi F, Fortuné Randriana R, Rasoanaivo P, Nicoletti M, Quassinti L, Bramucci M, Lupidi G, Petrelli D, Vitali LA, Papa F, Vittori S. Chemical composition and in vitro biological activities of the essential oil of Vepris macrophylla (Baker) I. Verd. endemic to Madagascar. Chem Biodivers. 2013;10:356–366. doi: 10.1002/cbdv.201200253. PubMed    

  77. Kuo YH, Kuo YJ, Yu AS, Wu MD, Ong CW, Kuo LMY, Huang JT, Chen CF, Li SY. Two novel sesquiterpene lactones, cytotoxic vernolide-A and-B, from Vernonia cinerea. Chem Pharm Bull. 2003;51:425–426. doi: 10.1248/cpb.51.425. PubMed    

  78. Dahham SS, Tabana YM, Iqbal MA, Ahamed MB, Ezzat MO, Majid AS, Majid AM. The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of Aquilaria crassna. Molecules. 2015;20:11808–11829. doi: 10.3390/molecules200711808. PubMed    

  79. Jung JI, Kim EJ, Kwon GT, Jung YJ, Park T, Kim Y, Yu R, Choi MS, Chun HS, Kwon SH, Her S, Lee KW, Park JH. β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet-induced obese C57BL/6N mice. Carcinogenesis. 2015;36:1028–1039. doi: 10.1093/carcin/bgv076. PubMed    

  80. Sarvmeili N, Jafarian-Dehkordi A, Zolfaghari B. Cytotoxic effects of Pinus eldarica essential oil and extracts on HeLa and MCF-7 cell lines. Res Pharm Sci. 2016;11:476–483. doi: 10.4103/1735-5362.194887. PMC free article  PubMed     

  81. Legault J, Pichette A. Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol. 2007;59:1643–1647. doi: 10.1211/jpp.59.12.0005. PubMed    

  82. Lesgards JF, Baldovini N, Vidal N, Pietri S. Anticancer activities of essential oils constituents and synergy with conventional therapies: a review. Phytother Res. 2014;28:1423–1446. doi: 10.1002/ptr.5165. PubMed    

  83. Savelev SU, Okello EJ, Perry EK. Butyryl-and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother Res. 2004;18:315–324. doi: 10.1002/ptr.1451. PubMed    

  84. Liu ZB, Niu WM, Yang XH, Yuan W, Wang WG. Study on perfume stimulating olfaction with volatile oil of Acorus gramineus for treatment of the Alzheimer’s disease rat. J Tradit Chin Med. 2010;30:283–287. doi: 10.1016/S0254-6272(10)60057-X. PubMed    

  85. Majlessi N, Choopani S, Kamalinejad M, Azizi Z. Amelioration of amyloid β-induced cognitive deficits by Zataria multiflora Boiss. essential oil in a rat model of Alzheimer’s disease. CNS Neurosci Ther. 2012;18:295–301. doi: 10.1111/j.1755-5949.2011.00237.x. PubMed    

  86. Cioanca O, Hritcu L, Mihasan M, Trifan A, Hancianu M. Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer’s disease. Physiol Behav. 2014;131:68–74. doi: 10.1016/j.physbeh.2014.04.021. PubMed    

  87. Oboh G, Olasehinde TA, Ademosun AO. Essential oil from lemon peels inhibit key enzymes linked to neurodegenerative conditions and pro-oxidant induced lipid peroxidation. J Oleo Sci. 2014;63:373–381. doi: 10.5650/jos.ess13166. PubMed    

  88. Abuhamdah S, Abuhamdah R, Howes MJ, Al-Olimat S, Ennaceur A, Chazot PL. Pharmacological and neuroprotective profile of an essential oil derived from leaves of Aloysia citrodora Palau. J Pharm Pharmacol. 2015;67:1306–1315. doi: 10.1111/jphp.12424. PubMed    

  89. Ayaz M, Junaid M, Ullah F, Sadiq A, Khan MA, Ahmad W, Shah MR, Imran M, Ahmad S. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A Preliminary anti-Alzheimer’s study. Lipids Health Dis. 2015;14:141. doi: 10.1186/s12944-015-0145-8. PMC free article  PubMed     

  90. Klein-Júnior LC, dos Santos Passos C, Tasso de Souza TJ, Gobbi de Bitencourt F, Salton J, de Loreto Bordignon SA, Henriques AT. The monoamine oxidase inhibitory activity of essential oils obtained from Eryngium species and their chemical composition. Pharm Biol. 2016;54:1071–1076. doi: 10.3109/13880209.2015.1102949. PubMed    

  91. Mühlbauer R, Lozano A, Palacio S, Reinli A, Felix R. Common herbs, essential oils and monoterpenes potently modulate bone metabolism. Bone. 2003;32:372–380. doi: 10.1016/S8756-3282(03)00027-9. PubMed    

  92. Koo BS, Lee SI, Ha JH, Lee DU. Inhibitory effects of the essential oil from SuHeXiang Wan on the central nervous system after inhalation. Biol Pharm Bull. 2004;27:515–519. doi: 10.1248/bpb.27.515. PubMed    

  93. Lima B, López S, Luna L, Agüero MB, Aragón L, Tapia A, Zacchino S, López ML, Zygadlo J, Feresin GE. Essential oils of medicinal plants from the central andes of Argentina: chemical composition, and antifungal, antibacterial, and insect-repellent activities. Chem Biodivers. 2011;8:924–936. doi: 10.1002/cbdv.201000230. PubMed    

  94. El-Seedi HR, Khalil NS, Azeem M, Taher EA, Göransson U, Pålsson K, Borg-Karlson AK. Chemical composition and repellency of essential oils from four medicinal plants against Ixodes ricinus nymphs (Acari: Ixodidae) J Med Entomol. 2012;49:1067–1075. doi: 10.1603/ME11250. PubMed    

  95. Mkaddem M, Bouajila J, Ennajar M, Lebrihi A, Mathieu F, Romdhane M. Chemical composition and antimicrobial and antioxidant activities of Mentha (longifolia L. and viridis) essential oils. J Food Sci. 2009;74:M358–M363. doi: 10.1111/j.1750-3841.2009.01272.x. PubMed    

  96. Hong YK, Park SH, Lee S, Hwang S, Lee MJ, Kim D, Lee JH, Han SY, Kim ST, Kim YK, Jeon S, Koo BS, Cho KS. Neuroprotective effect of SuHeXiang Wan in Drosophila models of Alzheimer’s disease. J Ethnopharmacol. 2011;134:1028–1032. doi: 10.1016/j.jep.2011.02.012. PubMed    

  97. Park SH, Lee S, Hong YK, Hwang S, Lee JH, Bang SM, Kim YK, Koo BS, Lee IS, Cho KS. Suppressive effects of SuHeXiang Wan on amyloid-β42-induced extracellular signal-regulated kinase hyperactivation and glial cell proliferation in a transgenic Drosophila model of Alzheimer’s disease. Biol Pharm Bull. 2013;36:390–398. doi: 10.1248/bpb.b12-00792. PubMed    

  98. Liu QF, Jeong H, Lee JH, Hong YK, Oh Y, Kim YM, Suh YS, Bang S, Yun HS, Lee K, Cho SM, Lee SB, Jeon S, Chin YW, Koo BS, Cho KS. Coriandrum sativum suppresses Aβ42-induced ROS increases, glial cell proliferation and ERK activation. Am J Chin Med. 2016;44:1325–1347. doi: 10.1142/S0192415X16500749. PubMed    

  99. Liu QF, Lee JH, Kim YM, Lee S, Hong YK, Hwang S, Oh Y, Lee K, Yun HS, Lee IS, Jeon S, Chin YW, Koo BS, Cho KS. In vivo screening of traditional medicinal plants for neuroprotective activity against Aβ42 cytotoxicity by using Drosophila models of Alzheimer’s disease. Biol Pharm Bull. 2015;38:1891–1901. doi: 10.1248/bpb.b15-00459. PubMed    

  100. Hur J, Pak SC, Koo BS, Jeon S. Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells. Pharm Biol. 2013;51:30–35. doi: 10.3109/13880209.2012.700718. PubMed    

  101. Tian LL, Zhou Z, Zhang Q, Sun YN, Li CR, Cheng C, Zhong ZY, Wang SQ. Protective effect of (±) isoborneol against 6-OHDA-induced apoptosis in SHSY5Y cells. Cell Physiol Biochem. 2007;20:1019–1032. doi: 10.1159/000110682. PubMed    

  102. Han M, Liu Y, Zhang B, Qiao J, Lu W, Zhu Y, Wang Y, Zhao C. Salvianic borneol ester reduces β-amyloid oligomers and prevents cytotoxicity. Pharm Biol. 2011;49:1008–1013. doi: 10.3109/13880209.2011.559585. PubMed    

  103. Calleja MA, Vieites JM, Montero-Meterdez T, Torres MI, Faus MJ, Gil A, Suárez A. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr. 2013;109:394–401. doi: 10.1017/S0007114512001298. PubMed    

  104. Sharma C, Al Kaabi JM, Nurulain SM, Goyal SN, Kamal MA, Ojha S. Polypharmacological properties and therapeutic potential of β-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise. Curr Pharm Des. 2016;22:3237–3264. doi: 10.2174/1381612822666160311115226. PubMed    

  105. Cheng Y, Dong Z, Liu S. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94:1–12. doi: 10.1159/000362689. PubMed    

  106. Porres-Martínez M, González-Burgos E, Carretero ME, Gómez-Serranillos MP. In vitro neuroprotective potential of the monoterpenes α-pinene and 1,8-cineole against H2O2-induced oxidative stress in PC12 cells. Z Naturforsch, C, J Biosci. 2016;71:191–199. PubMed

  107. Sammi SR, Trivedi S, Rath SK, Nagar A, Tandon S, Kalra A, Pandey R. 1-Methyl-4-propan-2-ylbenzene from Thymus vulgaris Attenuates Cholinergic Dysfunction. Mol Neurobiol. 2016 doi: 10.1007/s12035-016-0083-0. PubMed   

  108. Lee Y. Cytotoxicity evaluation of essential oil and its component from zingiber officinale roscoe. Toxicol Res. 2016;32:225–230. doi: 10.5487/TR.2016.32.3.225. PMC free article  PubMed     

  109. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils-a review. Food Chem Toxicol. 2008;46:446–475. doi: 10.1016/j.fct.2007.09.106. PubMed    

Leave a comment

Withholding The Cannabis Chorea Cure = Pig Pharma Profits

What if there were a natural medicine that could control Huntington’s Chorea, as well as chorea stemming from other non-genetic diseases and conditions, and perhaps arrest the progression?

What if instead of having to take a medicine that may force you to think about suicide, as so many chorea victims do, you could take the extract of a simple flower and re-discover how good life is without chorea?

What if the medical profession published numerous medical journal articles about this natural medicine 150 or so years ago, when it was a standard successful treatment for chorea?

And finally, what if for the last 80 years or so the combined power of the US government and Pig Pharma corporations had made possession of this natural medicine grounds for slamming you in prison for a long, long time? That would be – let’s see, what’s the opposite of “Awesome”?

Huntington’s disease is a neuro-degenerative disease and most common inherited cause of chorea. Other non-inherited causes of chorea are show in the graphic above.

Chorea is characterized by brief, semi-directed, irregular movements that are not repetitive or rhythmic, but appear to flow from one muscle to the next. When chorea is serious, slight movements will become thrashing motions.

The characteristic movements of chorea often include twisting and writhing. Walking may become difficult because of uncontrollable body postures and leg movements.

Unlike ataxia, which affects the quality of voluntary movements, or Parkinsonism, which is a inhibition of voluntary movements, the movements of chorea occur involuntarily, without any conscious effort to move a limb, an extremity (hands or feet), the head or neck, or any other part of the body. Because all movements associated with chorea are involuntary, it is classified as a hyperkinetic movement disorder.

The only answers that Pig Pharma has for Chorea are treatments, not cures. One of the most commonly prescribed “medicines” is tetrabenazine. Among the risks associated with tetrabenazine’s use are: sedation, fatigue, insomnia, akathisia, anxiety and nausea. Oh, and also tetrabenazine increases the risk of depression and suicidal thoughts and behavior in people afflicted with Huntington’s disease. So it doesn’t cure you, but it may make you decide to kill yourself. Nice drug. All the other Pig Pharma answers to Huntington’s Disease pose similar risks and do not cure Chorea.

In fairness, it is important to point out that one of the following reported cases of someone with chorea who was healed by Cannabis, was a young girl who had suffered from a bout of rheumatic fever a month prior to the onset of Chorea. It is well-established (in 2018) that one type of Chorea, Sydenham’s chorea, occurs as a complication of streptococcal infection, and that twenty percent of children and adolescents with rheumatic fever who are left untreated with antibiotics develop Sydenham’s chorea as a complication. So it is possible, even likely, that what Dr. Douglas is describing is a strep infection leading to Chorea – in other words, a sub-set of Chorea. However, since Cannabis is not an antibiotic, it seems unlikely that in this case being described its beneficial use in the treatment of Chorea would be confined to this single sub-set of the disease. Plus the instance of this young girl is only one of many Cannabis chorea cures that are described in this medical journal article from 1869.

Fortunately for people suffering from Huntington’s today, in most places Cannabis is available for self-treatment, and in the more advanced states there are even physicians who have bothered to learn and build on what their colleagues discovered 150 years ago, ignoring the poisons being pushed by Pig Pharma.

Here is one example of what has been known and withheld from those who suffer for eight generations. The research isn’t perfect, and the doctor is very much trapped in many of the false assumptions of his day, but he is clear on one thing – Cannabis is a powerful natural medicine that is safe and effective for treating neurological diseases like Chorea.


By Dr. Douglas F.R.G.P.E.

Vice-President of the Medico-Chirurgical Society of Edinburgh

February 4th, 1869


The value of Indian hemp as a therapeutic agent is well established, but a singular difficulty has been experienced in securing for it the confidence to which it is evidently entitled. Without attempting to explain or to excuse this difficulty, I propose to illustrate what appears to me one of its most useful applications.

The negative virtues of the drug are amongst its chief merits. Dr. Russell Reynolds, who writes one of the most recent, and one of the best expositions of the value of this remedy, tells us, as the result of a manifestly practical and thoughtful experience, that it is a soporific, anodyne and antispasmodic; and that it relieves pain and spasm: that it does not leave behind it headache nor vertigo; nor does it impair the appetite nor confine the bowels. These important virtues accord with anything I have seen of its action; nor have I met with any annoyance in practice from its peculiar action on the emotional or intellectual state of the sick. We are apt to be deterred from the use of a remedy by such pictures of its more peculiar actions, as are given of the abuse of the drug in countries where it is resorted to as a means of intoxication, and of its action in the cases of patients who under its use became tortured by ocular illusions and spectres of horrible form.

I do not doubt that such effects result from the use of the drug; but, in prescribing it, I have not met with them, and I am disposed to think that they are to be avoided even more certainly than we can guard against the unpleasant effects of opium.

As in the case of other useful drugs, the contradictory and extreme views of the efficacy and certainty of its therapeutic action, urged by writers of high authority, have retarded confidence in cannabis Indica; and indeed its applications to disease seem scarcely to have been investigated with the reliance which its demonstrated energy would justify. It is now many years since Dr. Dominic Corrigan published a series of cases which underwent cure in the course of four or five weeks, mainly by the use of the cannabis Indica, in doses of five minims of the tincture, increased to twenty-five: one of the cases, being of ten years standing, was cured in a month. (Archives of Medicine. Edited by Lionel S. Beale, M.B. Vol. ii. London Medical Times, 1845.)

One cannot resist the impression that other elements in the treatment, besides the administration of the cannabis, had need to be taken into account in the explanation of such cures; and moreover, before the actual value of the drug in such cases can be determined, a minute statement of the clinical and pathological relations of each case would be required i.e., how far the case might be one of chorea arising in connexion with rheumatism, struma, cerebral or spinal disease, or in connexion with some more temporary source of irritation in the system, as from derangement of the digestive or of the generative or other functions.

Again, we find Dr. Wilks of Guy’s Hospital arguing that, because fifty remedies have been found to cure such a disease as chorea, it may be safely left to itself. Accordingly, Dr. Wilks, admitting the usefulness of Dr. Hughes favourite and useful remedy, rhubarb steeped in port wine, prescribes to his patients the syrup of orange, that students may witness the spontaneous cure of the disease; and his patients, like Dr Corrigan’s, left the hospital cured in about a month.

Nevertheless, whatever preference we may have for a medicine expectant, that permits the sick to recover, over the heroic measures, whose advocates claim to have cured the patients who escape out of their hands, thoughtful practitioners will not be prevented from inquiring into the nature and the extent of special therapeutic actions by the scepticism of doubters nor by the rash generalizations of hasty observers.

Jane Williamson, aged 13, was admitted into the Chalmers Hospital under my care on the 15th of October last. She had the look of previously good health, and she was well nourished, but not robust. At the date of her admission, she presented the awkward gesture and the grimace of established chorea, though not severe in its degree. Temperature was natural; pulse 90, rather small; there was slight rheumatic pain of the knees and elbows, and an excited state of the heart’s action. The urine was loaded with lithates, it was normal in density, about 30 oz. in twenty-four hours. The bowels were easily regulated.

The treatment, in the first instance, consisted in the administration of a solution of the acetate of potash, with infusion of digitalis, and four minims of Fowler’s solution thrice a day.

The history of her previous illness given by herself and her friends was that, about a month previously, she was taken with a not intense attack of rheumatic fever. She suffered a good deal from the state of the larger joints; no symptom of cardiac inflammation appeared to have existed, but, for about a fortnight preceding her admission, she presented choreal action, gradually increasing indegree and affecting the extremities and face. . .

During the days immediately succeeding her admission, a rapid change occurred in the degree of the choreal movements, and in the state of the heart’s action. The latter became so disturbed, feeble, and excited, with feeble arterial pulse, as to cause serious anxiety for the safety of the patient, and at the same time the choreic agitation increased with such violent restlessness and 1 oiling in bed that excoriation occurred over the sacrum and both nates, while contortion of the features and tossing of the extremities, especially when their movement was attempted, continued excessive, the articular effects of rheumatism decreased, temperature became more natural, and urine healthy, but the bowels became torpid. The arsenic was persevered with, and a few 30-grain doses of bromide of potassium were given. Each dose was followed by a short period of quiescence, but, on the 20th, the excitement of the heart’s action became so alarming that 25-minim doses of tincture of Indian hemp were administered, followed by apparently marked, but only transient abatement of the spasmodic movement, which, as Dr. Hogg, the resident physician, reported, seemed to recur subsequently with increased and distressing severity.

On the following day, that is, the sixth of her residence in the Hospital, her condition seemed desperate, chiefly on account of the protracted and uncontrollable hurry of the heart’s action. She was ordered to have six minims of the tincture of cannabis every hour, the arsenic and other remedies being intermitted. The bowels were now well regulated, the excoriations of the back and nates had increased so as to form superficial sloughs of considerable extent, the pulse was small and so rapid as not to be counted, and the heart’s action was still feeble, rapid, and disturbed. She had four ounces of brandy per day. On the following day, having had twenty doses of the tincture, there was marked and increasing improvement. The violence of the tossing and rolling had diminished materially, though still it was necessary to have her secured in bed to prevent her falling or rolling over. From this time till the 15th day of her residence in the hospital, the tincture was administered from hour to hour, and she continued to make daily and progressive improvement. At that date (the 28th) she had been free of all the more violent spasmodic movements for two days and the heart’s action was quiet, pulse about 80, appetite good, bowels regular. She still presented a degree of the peculiar grimace, with awkwardness in protruding the tongue and in movement of the arms and hands. There was great mental lethargy, with languor and exhaustion, which made it impossible for her to be out of bed.

The tincture of hemp was now discontinued, and arsenical solution in four-minim doses resumed.

The subsequent progress of the case, though tedious, and so far disappointing, may be told in a few sentences. On the 1st of November, and on several occasions during the rest of that month, there occurred a renewal of the choreal state, which had not indeed absolutely disappeared, though it was often so trivial and even absent as to encourage the hope of an early recovery. Arsenic was perseveringly employed, with a carefully-regulated diet and general management, but on each occasion, of which three were noted, when an exacerbation of the choreic condition arose, a marked abatement of the muscular action resulted from the administration of small and hourly-repeated doses of tincture of hemp, relief sometimes arising so speedily as within six or eight hours. On one occasion the improvement was not decided for three or four days.

In the beginning of December, rheumatic symptoms recurred with slight febrile action and articular pains and renewal of choreic agitation. At the same time, marked excitement of the heart’s action was renewed, and now, for the first time, a faint soft diastolic murmur, indicative of aortic regurgitation, was with difficulty perceived. A weak solution of acetate and nitrate of potash was administered, and grain doses of opium four or five times in twenty-four hours. Pain arid fever abated, but not the spasmodic movement, and on the third day afterwards six-minim doses of tincture of hemp were given every two hours, followed by an immediate decrease of the chorea, which at once declined to its slightest degree in two or three days.

The patient now presented more marked indications of returning health. The state of mental lethargy into which she had early lapsed was now passing off; her appetite was revived, and on the 20th December she was able to be out of bed and to walk with assistance. Small doses of the iodide of potassium with the infusion of quassia were given, and improvement went on uninterruptedly; she did not, however, cast off the choreic jerk and awkwardness till the second week of January 1869. She has since had a very comfortable convalescence, but the diastolic murmur noted above continues strongly developed.

In the remarks I have to offer on this case, I confine myself to the points which illustrate the value and application of cannabis Indica in the treatment of choreal spasm. It is well said by Dr. Hughes, that each case of chorea, like each case of every other disease, should be separately studied; and though it may be regarded as one of a class, should still be viewed as a distinct individual of the class. In the case of my patient, the general characteristics of the attack point it out as an example of a large class of cases in which acute rheumatism constitutes the primary and originating source of chorea, while its special features simply declare the degree of chorea, with its repeated recurrences, and the unusual violence of agitation, to have been more than ordinarily severe, without any such personal or inherited constitutional peculiarity as exists in certain forms of this and of other nervous diseases.

Connected with the severity of the chorea, an inquiry of some difficulty arises out of the condition of the heart, particularly its disturbed action in the early stage, and the endocarditic lesion which occurred later, and which declared its presence only with the renewed rheumatic attack in the beginning of December. At the time of her admission and subsequently, notwithstanding the extra-ordinary hurry of the heart’s action, I persuaded myself that there was no organic nor inflammatory lesion, and I came to the conclusion that the severity of the choreic state had extended to the heart. The evidences of endocarditis subsequently developed cast doubt on my view of the previously choreic state of the heart; and there does not appear to be any means of solving the question beyond the opinion of those who saw the patient.

It certainly seems unlikely that endocarditis capable of causing such extreme disturbance of the heart’s action should have existed, unaccompanied from the outset by other indications of its presence.

This point possesses some interest in connexion with the view advanced by Dr. Russell Reynolds, that Indian hemp has been of no service in those affections of mind, sensation, or motility, which are simply functional in their character, or, at all events, have no established morbid anatomy. On the other hand, that it has afforded notable relief in cases where organic disease existed.

I do not agree with this view, but it would be beside my object to discuss it here. On the supposition, however, that the view is a sound one, it suggests that, in my patient, the organic lesion had originated in the heart at an early stage of the attack, and, consequently, the beneficial effects of the cannabis were so readily exerted. On the whole, the conclusion is a fair one, that endocarditis was present earlier than appeared; though still, I cling to the view that the disturbed action was, in the first instance, functional and choreic.

The practical interest of my case, however, consists in the illustration it affords of the special use and application of cannabis in the treatment of choreal spasm, and of the mode in which the remedy may be administered in many cases, if not in all. I have already remarked on the mistake, as it seems to me, of looking for general curative results in this or in any disease from the mere general application of special therapeutic observation or experience.

I think the cases and cures of chorea by tincture of hemp reported, to whlch I have referred, illustrate the fallacy of such reasonings; but, on the other hand, the case of my patient suggests that there is a special, and perhaps a frequently useful, application of the drug in such circumstances. The impression which the case leaves on my mind is, that cannabis has a peculiar value and power in controlling the irregular movements of chorea, which ever and again are terribly distressing, and possibly even dangerous, to the patient; and it would be of no small moment to determine the extent and limit of its influence, and to ascertain whether or not choreic action, even in slighter cases, might not be moderated by this remedy.

The result of repeated trial in my patient seems to show, on the one hand, that the violence of choreal action was speedily moderated; and the protracted duration of the case, on the other hand, makes it sufficiently evident that the virtue of the remedy did not reach farther in the direction of removal and radical cure of the disease. This points to an important question in the treatment of chorea, which has been mooted by many writers on the subject, viz., how far the chorea is to be dealt with as an independent condition, and how far its treatment and removal will be best achieved by the treatment of the diseased state out of which it has sprung?

I think that systematic writers and clinical lecturers have dealt with the subject of chorea too much as an independent disease, and that the late Dr. Babington, of London, in his justly-admired paper on chorea, indicated a sound and philosophic principle, when he advised that when the disease has arisen by metastasis of rheumatism, it should be treated in the same way as pericarditis is treated.

Recognising, then, the principle that our chief aim in the treatment is to combat the constitutional state, or the local disease in connexion with which the chorea has arisen, I conclude farther, from the case I have read, that an important aim must sometimes, if not at all times, be to allay the severity of the choreal state by the use of cannabis, or by other means. On this point, I cannot resist quoting from M. Trousseau his earnest utterances in the behalf of tartar emetic as a means of subduing the violence of choreal agitation: “Unfortunately,”says that learned physician, “there are cases in which the convulsive agitation is of such violence that all known means are without avail, and the physician too often sees poor young girls perish miserably, the skin rubbed and deeply ulcerated by incessant friction, that no appliance can obviate.

But surely, in such circumstances, cannabis Indica is a far more appropriate remedy than tartar emetic, affording, as M. Trousseau adds, “if  though only in exceptional cases, a chance of success where  we appeared impotent.”

The limit of the therapeutic action of cannabis Indica in these cases is incidentally indicated, with a thoroughly practical wisdom, by Dr Williams and by Dr Walshe. So long ago as in 1843, Dr Williams is reported to have said, in the course of a discussion, that he had found it “ relieves chorea during its exhibition, but without radical effect on the disease.”

In 1849, Dr Walshe, in a clinical lecture, says: “Not only was its sedative effect marked in degree, but it was almost immediate in point of time, leaving no doubt on my mind as to the reality of its influence.”

The recurrent attacks of chorea in the case of my patient afforded the means of direct illustration of the efficacy of the drug in subduing the choreal state. for repeatedly the same result was witnessed in the speedy and more or less complete subsidence of the agitation under the use of the remedy, and the decided effect produced on the heart’s action tends to confirm me in the impression that the disturbed state of that organ was largely choreal.

As to the mode of administering the remedy, small and frequent doses proved both safe and effective, and great advantage appeared to arise from increasing the frequency of the dose rather than its amount. Believing, as I do, that cannabis Indica is a remedial agent of value in many and various maladies, I am prepared to recommend this mode of seeking its effects by frequent rather than by larger doses at longer intervals. Such a mode of prescribing it has not been usual; but I find, quoted from an American source, the account of a case of hiccup treated in this way by eight-drop doses of a fluid extract, administered hour by hour, in which recovery from an attack that had defied treatment for five days took place in a few hours.

I have brought this case under the notice of the Medico-Chirurgical Society, not on account of any novelty in its history, nor on account of any conclusions it very positively points to, but simply to bring anew to the light of day an important therapeutic fact, which seemed like to be buried in the pages of undisturbed magazines, and which, probably, has an important application, not only to distressing and dangerous cases of chorea, but even to slight and ordinary cases, as well as to cases of other spasmodic diseases, such as hiccup, irritable heart, asthma, tetanus, and the like.

If you would like to have a copy of this 1869 article by Dr. Douglas as a PDF file please email me with your request.


Leave a comment

Poppy Juice, Synthetic Pills, & The Trap Of Addiction

“The Intercept” has just run an excellent piece outlining the lobbying efforts of the Opioid Manufacturing sector of the Pharmaceutical Industry to scuttle new Federal regulations that would attempt to make it harder for doctors to prescribe Opioid drugs like Oxycontin. The major manufacturers involved in the lobbying are Purdue, Cephalon, Endo, and Janssen (a subsidiary of Johnson & Johnson).

The efforts of these parasitical manufacturers to maintain open season on the wholesale addicting of new “patients” while at the same time keeping up the flow of millions of tablets of these drugs that somehow manage to leak into the street market ( who, us?), is symptomatic of the thug-like nature of virtually the entire pharmaceutical industry.

When you look at the numbers you see that pills are the main “Opioid” killers, not Heroin, not Morphine, and certainly not Opium from the Poppy, and for all the hype about synthetic Opium pills like Oxy, the job they do of relieving pain is no better than a pipe of good opium. Of the 47,000+ drug overdose deaths counted by the CDC in 2014, 8800 were due to Heroin, which leaves +38,000 due largely to pills.

The single justification for the “Opioid” pill industry’s existence is that their products are claimed to be safer than natural Opium, Morphine, or Heroin. If you want to find the reason for the industry’s panic at the increase in Opioid pill deaths, look at the ratio between deaths from the dreaded slayer of youth Heroin and the supposedly safe if used as directed wonder pill.

If a huge part of your industry’s claim to fame is that your product is safer than the juice of the poppy then you have to be pretty upset when people are finally realizing that your pills are killing users nearly 5:1 compared to the fruits of the little flower.

Consider for a moment two possible tracks for our society – the one we are on and the one that could have been, and yet might be.

The track our society has taken is to turn our health, just like we’ve turned most of the other key aspects of our lives, over to highly intrusive institutional management. Most of us no longer have any management role in our food, our children’s education, our family and community security, our finances, or our privacy. One of the results of our capitulation to pervasive institutional management of our lives is that the exponentially-growing health industry, always quick to spot (or make) an opportunity, responded by creating vast numbers of expensive, enormously profitable drugs for all those astounding new diseases of modern society that patients are required to take by their doctors who give no natural options in place of the medical management system’s proprietary pharmaceuticals.

The second track, which might have been, is that all of the medical knowledge gained by doctors, patients and society at large in the 1700s and especially the 1800s regarding three of the great natural drugs – Opium, Coca and Cannabis – might have been kept and nurtured rather than discarded and largely forgotten. Had those three natural medicinal drugs not been demonized and outlawed as part of the warped spiritual movement of the early 1900s that gave birth first to Prohibition and later to the War On Drugs, these three great natural drugs would be available today as a part of the :People’s Pharmacy” just like hundreds of other herbal, natural medicines.

The industrial pharma industry would still have developed, and a lot of people would still be victims of their concoctions, but without the legal framework lovingly erected over decades by authoritarian conspirators there would be a whole segment of the Medical industry devoted to the use of all natural medicines, not just those permitted by the state as part of its role in enforcing the monopoly of Industrial Pharma over medicinal products.

Even more important, a nationwide, community-bases network of natural medicine practitioners would have evolved – people in every community who knew how to grow all of the ancient medical herbs and who utilized the advances of technology to produce ever-more effective but still natural medicines.

Of course we have a great model for this system in the network of Medical Cannabis growers and patients who are finally emerging after the long night of Prohibition – which is still in the very earliest stages of dawning – to point to and see what might have been for ALL the great natural medicines and not just Cannabis, and not just in a few states in the US and a few countries in the world.

In a society where those who wanted any form of any natural drug could grow and prepare it for themselves, or could go to a reputable dispensary or belong to a regulated collective, then we would certainly have some addicts among these people, but they would be able to lead as normal a life as they chose to live without the constant suffering, pain, and jeopardy of addiction to “illegal drugs” and all the horrors that go with that scene.

People with little income would not be driven to prostitute themselves and do violence to feed a drug habit if the drugs they wanted were freely available in safe, natural forms. It is possible, is it not, that given access to natural drugs in a climate free of violence and exploitation many if not most people could use drugs and still lead a normal life even if trapped in circumstances of poverty.

I believe that centuries of recorded experience in societies worldwide shows that the overwhelming problem with addiction is how society treats addicts. If an addict is free to lead an otherwise productive and normal life, many will do so, and those who won’t would have been lost whether drug laws made them criminals or not.

Perhaps what makes addiction so awful for so many people isn’t what the drug does to them, it’s what society does to them as a consequence of their addiction. The popular image of addiction is what is used to sell all the prevention/intervention programs that flourish around addicted people. Human degradation in every form is shown as a consequence of drug addiction, and many people buy that and think no further. But consider the number of people who are technically addicted who lead normal, productive lives in comparison with those whose lives are supposedly ruined by addiction, you begin to realize that plenty of people are addicted to drugs and other substances and don’t descend to street prostitution, emaciation, bleeding scabs and sleeping in alleys. It seems that one begins to see that maybe it is circumstances and not the drugs themselves that determine the direction that addiction takes. Remove all the harsh punishments for addiction and I wonder – what would happen to addiction?

If the illegal status of drugs and the consequences for addiction were removed, at least drug addiction would no longer be part of the trap that ensnares millions of people in the US. Poverty and exploitation would continue in other ways – unless of course (you never know) some kind of new dynamic was released in poor communities by removing the key role of criminalized drug addiction in keeping the iron collar of poverty and exploitation firmly clamped around their necks.

1 Comment

Medical Marijuana – The View From 1984

Magic carpet w_guy

Thank you for visiting my blog. I thought that you might find this chapter from my 1984 book “Marijuana Foods” interesting in light of how widespread the acceptance of Medical Marijuana is these days, and how much research is now available to confirm the reality. The illustration is by the wonderful artist Pat Krug, who illustrated the book.

But, as you can see, even thirty years ago ( Lord, has it really been that long?) there was plenty of evidence that Marijuana is a gift from nature intended for the healing and enlightenment of the human race. Of course in those days young people were still being sentenced to 50 years hard time for the possession of a joint, so the idea of Marijuana as medicine did not compute except to the awakened few.

I hope that my books helped move the cause along, and I hope that you will especially enjoy the last section of this chapter “A Revolution In Caring”.

Chapter 5: Marijuana As Medicine
All materials Copyright © 1984 by Bill Drake
All Rights Reserved

Dear Reader. It is very important that you know that many of the medical and scientific literature references in this section are several years old. It is important that you independently inform yourself of the latest research in these areas before making any decisions about the personal medical use of Marijuana for any medical condition.

Table Of Contents

• Smoking Marijuana For Self-Medication
• Marijuana Food For Self-Medication
• Marijuana Beverages For Self-Medication
• Marijuana Smoke Enema For Self-Medication
• Marijuana Suppository For Self-Medication
• Marijuana And Self-Medication
• For Nausea and Vomiting
• As an Anticonvulsant
• In Movement Disorders
• As a Muscle Relaxant
• For Glaucoma
• In Bronchial Asthma
• For Hypertension & Anxiety
• For Insomnia
• In Eating Disorders
• In Treating Alcoholism
• Clinical Trials with Marijuana
• A Revolution In Caring
• Are You Shocked?

If you are thinking of using Marijuana for the first time you may not be aware that you have a number of options besides smoking. While smoking Marijuana is not as dangerous as smoking cigarettes, largely because homegrown Sinsemilla Marijuana is almost always organic and all commercial cigarettes have dozens of unregulated known carcinogenic chemical contaminants, if you aren’t a smoker and have a need for Marijuana for medical reasons, you don’t have to start smoking unless you want to.

Since smoking Marijuana is probably the most common current way to use it, we’ll begin with a look at several different smoking-related options.

Smoking Medicinal Marijuana

Probably the only way most people think of using Marijuana is by smoking a joint or a waterpipe. The principal reason for smoking Marijuana is that it produces almost instant effects since the lungs are very efficient at absorbing the complex chemicals in the smokestream. Recreational users call this a rush, and it feels almost exactly like what happens when you stand up too fast after sitting for a long time on a very hot day. Another way to describe it is that it’s like the biggest dizzy feeling you ever felt as a kid.

While the use of a waterpipe cuts way down on the irritating qualities of Marijuana smoke, not everyone likes to fuss with keeping a pipe clean. A waterpipe does lower the temperature of the smoke as well as filtering a lot of the soot and tar. It is also a little less wasteful than a joint because the pipe is a more efficient burning mechanism. If you use a waterpipe you’ll find that over time it develops a glaze of residue that daily washing with soapy water won’t remove. Just fill a plastic container with cheap white vinegar and immerse your waterpipe and all its components in the vinegar overnight and the next morning they’ll sparkle plenty.

Hand-rolled joints are a strong favorite because of convenience as well as portability. If you don’t know how to roll a joint, ask a doctor (yeah, right) or a friend for help. Never buy a pre-rolled joint, and you are better off not accepting one from anyone except someone you really trust. Even if a saint gives you a joint it doesn’t hurt to ask if there is anything but Marijuana in it. Sometimes people have perverse ideas of how to do a friend a favor.

In some cases government-produced joints will be available. It’s up to each individual to decide if they want to use Marijuana this way. It has the advantage of being strictly dosage-controlled. Federal Marijuana has the disadvantage of being too mild for effective relief of many symptoms, and for use in a holistic situation where the high is an integral part of the therapy. However, drug-naive physicians may be attracted to the administration of federal Marijuana because it’s available at a dosage which has known effects and references in clinical literature. (Of course, that same clinical literature ignores the potential of the whole natural Marijuana flower, for reasons discussed elsewhere, so its value is really pretty limited unless you are a pharmaceutical company looking for profitable new drugs to synthesize and manufacture.)

Eating Marijuana Food For Self-Medication

The principle advantages are smoke-free access to the therapeutic benefits of Marijuana, a sense of variety, cost effectiveness, dosage control, and duration of effective relief. Marijuana extract prepared and served as food enhances the experience of using the flowers of this great plant for their healing powers. It can be prepared and served so many natural ways that it can become a part of many different approaches to healing.

When consumed in very low dosage in foods the relief and associated Marijuana high arrive gently and stay a long while. They are a natural accompaniment to both quiet relaxation and energetic socializing, depending on the mood, the setting, and the objectives.

Marijuana Beverages For Self-Medication

Drinking a Marijuana beverage may be tolerated when food is not, for a variety of reasons. Many of the direct effects of chemotherapy and radiation make the intake of anything, even therapeutic food somewhat difficult. In such cases, where no other approach is preferred, a sip or two of a pleasant Marijuana liqueur or cordial is both a pleasant and effective alternative. The liqueur/cordial also offers easy, fast absorption and onset of relief, and effective duration of relief. They are easily stored and carried with you, and are a very cost-effective way to use Marijuana.

You’ll find a wide range of herbal and fruit beverages you can make with marijuana extract in the recipe sections of this book.

Marijuana Smoke Enema

Our age sometimes prides itself on having seen and done everything, but the Anal Hookah, as a friend with a dark sense of humor called this approach, appears to have been first developed in the 16th century by the Dutch as a means of bringing drowning victims back to life. The then-newly discovered American herb Tobacco was being used back then for many different medical applications during the early days in Europe, and the Tobacco Smoke Enema for drowning victims was one of the more useful treatments of its time and by all accounts was used successfully hundreds of times.

I’ve tried to picture how this remarkable discovery was made. It must have been a tragedy involving a drowning in one of the Dutch canals, with everyone standing around crying and yelling “Can’t somebody do something!” Nearby stood a Dutchman – perhaps a physician himself – smoking his pipe and feeling quite moved by the scene. If he was like most Dutch people I know, he was a very private person and would never allow another person’s lips to touch his pipe, making what happened next a remarkable act of compassion.

In a moment of pure selflessness – or maybe he just needed a good excuse to buy a new pipe, though that would be unlike most of my Dutch friends of today – he must have walked up to the crowd gathered around the drowned person and said something like – “Ahem, er um, well, if nobody has any objections, I could try blowing a little tobacco smoke up this poor soul’s rectum. My first puff in the morning certainly wakes me right up.” The crowd must have been stunned, then someone must have cried out “Just do it!” – and the rest was medical history, at least for a few decades in Holland.

The Dutch might have invented it and used it to good effect, but the rest of the queasy world was evidently not ready for the Tobacco Enema even to save lives, since I’ve seen no evidence of it around emergency rescue vehicles and lifeguard stands, nor on TV.

Nevertheless, over the years since I saw my first picture of an actual 16th century Tobacco smoke enema syringe I have quietly circulated the idea of Marijuana smoke enemas when I have been approached for information and suggestions by people with complications which precluded other approaches and where a quick result was desired. I recall a particularly effective use of the Marijuana smoke enema with a person with severe asthma, unconscious from a car wreck.

If the situation is such that a person can’t tolerate any other form of Marijuana, the Marijuana smoke enema may be effective, such as when the person is unconscious or otherwise unable to cooperate. There’s no need for an elaborate apparatus; simply taking a rubber or plastic enema tube with the bag removed and the tip in place, inserting it, taking a draw on a joint or waterpipe, and blowing little puffs into the rectum.

Puff- don’t blow. Very tiny little puffs, a few at a time and then wait. If the person is conscious and can report effects, it should be less than 15 minutes before they are felt, and more smoke can be given if needed – but be sure to give the first puff or two time to come on completely, since this is often all that’s needed. Experimenters have observed that the high by this route is as rapid as with the lungs but has “deeper” qualities, perhaps because of the greater central nervous system involvement in this area of the body.

A further advantage of this approach is that the active substances in the smoke are rapidly absorbed by the blood in the tissues, and there is almost nothing left behind to irritate the area when the therapy is completed, as there is in the case of suppositories.

While not recommended for extended use, this method offers a clean, safe way for a very ill person to get immediate relief without trauma as long as both the sick person and the person assisting in the administration of the therapy are either broad-minded and tolerant, or a little kinky, or both.

Marijuana Suppository For Self-Medication

Marijuana extract suppositories are a potentially useful approach when a person is unconscious or otherwise unable to cooperate. It is also an option when the throat, stomach, lungs and GI tract are involved in disease and the benefits of Marijuana are desired. The suppository approach offers a slow-onset high, very effective absorption, and long-lasting relief from small dosages.

An effective Marijuana suppository is made by hand-forming Marijuana butter extract into a little “bullet” about 1/2 inch long and as big around as a regular pencil. (Cocoa butter is also an efficient absorber of Marijuana potency and can be used to prepare these suppositories if there is an intolerance of regular butter extract.) Another approach making suppositories is to do a Marijuana/Oil extract with pure (not toasted) sesame oil, decant into capsules designed to melt in the rectum, chill and then insert.

The Research Picture – Marijuana And Self-Medication

In combination with what was already known from folklore and traditional medicine Marijuana researchers over the last 25 years have uncovered and confirmed some pretty astonishing indications of Marijuana broad potential as a therapeutic, and in some cases healing drug. In this section we’ll look briefly at the major areas of disease, injury and other trauma or condition where research scientists have shown Marijuana to be useful.

If you are being treated by a medical professional and choose to use Marijuana to address problems associated with your therapy you should discuss your decision prior to entering your course of therapy. There may be good reasons why you not use Marijuana, regardless of its potential for relief. There are quite a few studies which show that people with diabetes and cardiovascular problems should be especially cautious.

Through use of the bibliography and your own research, and information which your doctor has, you both will be able to discuss the matter factually. However if all you are offered is anti-drug propaganda, try another Doc.

For Nausea and Vomiting (emesis) associated with chemotherapy and radiation therapy.

Marijuana has the proven ability to alleviate the symptoms of both anticipatory nausea/vomiting as well as the nausea/vomiting actually connected with chemo or radiation. There’s not really any need to say much more. This is one of the few areas so well researched that there have even been clinical trials of people smoking joints of street Marijuana.

Use of Marijuana for anti-emetic relief is so well established that nobody facing either kind of therapy for any reason should deprive themselves of its benefits. Now that the smoke-free alternatives in this book are available there is no reason why an appropriate way of using Marijuana cannot be found.

Some Useful Readings

Ahmedzai, S, et al. 1983. Antiemetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. British Jour. Cancer, 48: 657-663
Artim, R. and DiBella, N., Tetrahydrocannabinol (THC) plus prochlorperazine (PCZ) for refractory nausea and vomiting (N/V), ASCO Abstr., 2, 85, 1983
Bakowski, M. T. 1984. Advances in anti-emetic therapy. Cancer Treatment Review 11: 237-256.
Bateman, D. N., Delta 9-Tetrahydrocannabinol and gastric emptying, Br. Journal Clinical Pharmacol., 15, 749, 1983
Borison, H., and McCarthy, L., Neuropharmacology of chemotherapy-induced emesis, Drugs, 25 (Suppl. 1), 8, 1983
Borison, H., Borison, R., and McCarthy, L., Phylogenic and neurologic aspects of the vomiting process, Journal Clinical Pharmacol. 21, 23S, 1981
Borison, H., McCarthy, L., and London, S., Cannabinoids and emesis, N. Engl. Journal Medicine, p. 1480, 1978
Brigden, M. R., and Barnett, J. B. 1989. Antiemetics and cancer chemotherapy. In: Nausea and vomiting: recent research and clinical advances. Edited by R. K. Harding, J. Kucharzyk, and D. J. Stewart. CRC Press, Inc., Boca Raton
Brigden, M., Wilson, K., and Barnett, J., Rational choice of antiemetic agents during cancer chemotherapy, Can. Fam. Phys.,29, 1682, 1983
Chang, A. E., Shiling, D. J., and Stillman, R. C., Goldberg, N. H., Seipp, C. A., Barofsky, 1., Simm, R. M., and Rosenberg, S. A., Delta-9-tetrahydrocannabinol as an antiemetic in patients receiving high-dose methotrexate: a prospective randomized evaluation, Ann. Int. Medicine,91, 819 1979
Chang, A. E., Shiling, D. J., Stillman, R. C., Goldberg, N. H., Seipp, C. A., Barofsky, 1., and Rosenberg, S. A., A prospective randomized trial of delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients receiving high dose methotrexate (MTX), ASCO/AACR., Proc., 20, 377, 1979
Chang, H. S. L., MacLeod, S. M., and Correia, J. A., Nabilone vs. prochlorperazine for control of cancer chemotherapy-induced emesis in children, ASCOAbstr.,3, 108, 1984
Citron, H.L., Herman, T., Fossierck, B., Krasno, S., Vreeland, F., Harwood, S., Ortega, L., and Cohen, M., Double blind randomized crossover study of the antiemetic effect of Levonantradol (LVN) vs. tetrahydrocannabinol (THC), AACR Abstr., 24, 165, 1983
Colls, B.M. et al,The antiemetic activity of THC vs metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy New Zealand Medical Journal, 1980: 91, pp 449-51.
Cone, L., Green, D., and Helm, N., Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting, Cancer Treat. Review, 9 (Suppl. B), 63, 1982
Cunningham, D., et al. 1985. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs. British Medical Jour. 291: 864—865.
Dodds, L.J., Journal of Clinical Hospital Pharmacology, The control of cancer chemotherapy-induced nausea and vomiting, 6/85, 10 (2) pp 143-66.
Dow, G. and Meyers, F., The California program for the investigational use of THC and marijuana in heterogeneous populations experiencing nausea and vomiting from anticancer therapy, Journal Clinical Pharmacol., 21 (Suppl. 8/8), 128S, 1981
Einhorn, L., Nagy, C., Furnas, B., and Williams, S., Nabilone: an effective antiemetic in patients receiving cancer chemotherapy, Journal Clinical Pharmacol., 21, 64S, 1981
Eyre, H.J. and Ward, J.H., Control of cancer chemotherapy-induced nausea and vomiting, Cancer, 12/1/84, 54 (11 suppl) pp 2642-8
Frytak, S. et al, Delta-9 THC as an antiemetic for patients receiving cancer therapy, Annals of Internal Medicine, 1979: 91, pp 825-30.
Frytak, S., and MOERTEL, C. G. . Management of nausea and vomiting in the cancer patient. Jour. Am. Medical Assoc. 245: 393 -396,1981
Frytak, S., Moertel, C. G., and O’Fallon, J. R., A comparison of delta-9-tetrahydrocannabinol (THC), prochlorperazine (PCP) and placebo as antiemetics for cancer chemotherapy, ASCO/ AA CR ., Proc., 20, 3 91, 1979
Garb, S., Cannabinoids in the management of severe nausea and vomiting from cancer chemotherapy. Some additional considerations, Journal Clinical Pharmacol., 21 (Suppl. 8/9), 57S, 1981
Gez, E., Biran, S., Fuks, Z., Edelstein, E., Lander, N., and Mechoulam, R., A marihuana component for nausea and vomiting induced by chemo and radiotherapy, Harefuah, 105(10), 306, 1983
Gralla, R., Tyson, L., Bordin, L., Clark, R., Kelsen, D., Kris, M., Kalman, L., and Groshen, S., Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol, Cancer Treat. Rep., 68(1), 163, 1984
Herman, T., Einhorn, L., Jones, S., Nagy, C., Chester, A., Dean, J., Furnas, B., Williams, S., Leigh, S., Dorr, R., and Moon, T., Superiority of Nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy, N. Engl. Journal Medicine, 300(23), 1295, 1979
Herman, T., Jones, S., Dean, J., Leigh, R., Dorr, R., and Moon, T., Nabilone: a potent antiemetic cannabinol with minimal euphoria, Biomedicine, 27, 331, 1977
Herman,T.S.,et al.1979. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N. Engl. Journal Medicine 300: 1295 – 1297.
Hisi, M., Niederle, N., Bremer, K., Schmitt, G., Schmidt, C., and Seeber, S., Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs, Dtsch. Med. U’ochenschr., 107(33), 1232,1982
Hoffman, R., Using Marijuana in the Reduction of Nausea Associated With Chemotherapy, Murray Publishing, Seattle, Wash., 1979
Homesley, H. D., Gainey, J., Jobson, V. W., Spurr, C., Welander, C., Muss, H. B., and Kimball, J., Failure of delta-9-tetrahydrocannabinol and prochlorperazine to control chemotherapy induced nausea and vomiting, ASCO Abstr., I, 67, 1982
Johansson, R., Kilkku, P., and Groenroos, M., A double-blind controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy, Cancer Treat. Rev., 9 (Suppl. B), 25, 1982
Jones, S., Durant, J., Greco, F., and Robertone, A., A multi-institutional phase-lll study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting, Cancer Treat. Review, 9 (Suppl. B), 45, 1982
Joss, R., Galeazzi, R., Bischoff, A., Do, D., Goldhirsch, A., and Brunner, K., Levonantradol, a new antiemetic with a high rate of side effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy, Br. Journal Cancer, 46(3), 492, 1982
Kaminski, M. and Erlichman, C., Current management of chemotherapy-induced nausea and vomiting, Ther. Rev., 38(1). 53, 1983
Kenny, J. and Wilkinson, P., Levonantradol effectiveness in cancer patients resistant to conventional antiemetics, Clinical Oncol., 8(4), 335, 1982
Krebs, H. B.,et al.1985. Combination antiemetic therapy in cisplatin-induced nausea and vomiting. Cancer, 55: 2645-2648.
Laszlo, J. 1982. Treatment of nausea and vomiting caused by cancer chemotherapy. Cancer Treat. Rev. 9(Suppl. B): 3—9.
Levitt, M., Faiman, C., Hawks, R., and Wilson, A., Randomized double blind comparison of delta 9-tetrahydrocannabinol (THC) and marijuana as chemotherapy antiemetics, ASCO Abstr., 3, 94, 1981
Levitt, M., Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients, Cancer Treat. Rev., 9, Suppl. B., 49, 1982
Levitt, M., Wilson, A., Bowman, D., Faiman, C., Kemel, S., Krepart, G., Schipper, H., Weinerman, B., and Weinerman, R., Dose vs. response of tetrahydrocannabinol (THC) vs. prochlorperazine (PCPZ) as chemotherapy antiemetics, ASCO/AACR., Proc., 22, 422, 1981
Levitt, M., Wilson, A., Bowman, D., Kemel, S., Krepart, G., Marks, V., Schipper, H., and Thomson, G., Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of Delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications, Journal Clinical Pharmacol.,21, 103S, 1981
Lucas, V.S. Jr. and Laszlo, J., Delta-9 THC for refractor vomiting induced by cancer chemotherapy, Journal of the American Medical Association, 1980: 243, 1241-43.
MacLeod, S., Chan, H., and Correia, J., Nabilone (N) vs. prochlorperazine (P) for control of chemotherapy-induced emesis in children, Can. Soc. Clinical Invest., 1984 Meeting, 7 (Suppl. 2), 1984
Maule, W. and Perry, .M., Management of chemotherapy-induced nausea and emesis, Pract. Therap. 27( 1 ), 226, 1983
McCabe, M., Smith, F. P., Goldberg, D., Macdonald, J., Wooley, P. V., Warren, R., Brodeur, R., and Schein, P. S., Comparative trial of oral 9-tetra-hydrocannabinol (THC) and prochlorperazine (PCZ) for cancer chemotherapy-related nausea and vomiting, ASCO/AACR., Proc., 22, 416, 1981
McCarthy, L. E. and Borison, H. L., Cis-platin emesis and cannabinoids in cats, Pharmacologist, 22, 448, 1980
Meyers, F., Stanton, W., Dow, G. and Rocchio, G., Reduced adverse effects with optimal antiemetic dosage schedule of delta-9-tetrahydrocannabinol (THC), ASCO Abstr., 3, 94, 1984
Minutes of Meeting on the Current Status of Research with Tetrahydrocannabinol and Nabilone for the Control of Cancer Chemotherapy-lnduced Vomiting, Department of Health Education and Welfare, Washington, D.C., 1978
Morrow, G. R. 1984. Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. Journal Clinical Oncol. 2: 11701 176.
Neidhart, J., Gagen, M., Wilson, H., and Young, D., Comparative trial of the antiemetic effects of THC and haloperidol, Journal Clinical Pharmacol., 21, 38S, 1981
Nerenz, D. R., et al. 1982. Factors contributing to emotional distress during cancer chemotherapy. Cancer, 50: 1020-1027
Nerenz, D. R., et al. 1986a. Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. Journal Clinical Oncol. 4: 224-237
Orr, L. and McKernan, J., Antiemetic effect of Delta 9 tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and Compazine, Journal Clinical Pharmacol., 21, 76S, 1981
Orr, L., McKernan, J., and Bloome, B., Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis, Arch. Int. Medicine, 140, 1431, 1980
Poster, D. S., Penta, J. S., and Bruno, S., Treatment of Cancer Chemotherapy-lnduced Nausea and Vomiting, Masson Publishing U.S.A., New York, 1981
Riggs, C., Egorin, M., Fuks, J., Schnaper, N., Duffey, P., Colvin, 0., Aisner, J., Wiernik, P., and Bachur, N., Initial observations on the effects of delta-9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin, Journal Clinical Pharmacol., 21 (Suppl. 8/9), 1981
Rivlin, R. S., Shils, M. E., and Sherlock, R 1983. Nutrition and cancer. Am. Journal Medicine 75: 843—854.
Sallan, S. E., and Frei, E., III. 1975. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N. Engl. Journal Medicine 293: 795—797
Sallan, S. E., Cronin, C., and Zelen, M., et al. 1980. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N. Engl. Journal Medicine 302: 135—138.
Sallan, S., Zinberg, N., and Frei, E., lll, Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy, N. Engl. Journal Medicine, 293, 795, 1975
Sallan, S.E. et al, Antiemetic effect of Delta-9 THC in patients receiving cancer chemotherapy, New England Journal of Medicine, 1980: 302, pp 135-138.
Schein, P., Delta-9 Tetrahydrocannabinol (THC) for the Prevention of Nausea and Vomiting Associated with Cancer Chemotherapy, Report to the U.S. Congress, Washington, D.C., 1980
Steele, N., Braun, D., O’Hehir, M., and Young, C., Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis, ASCO/AACR Proc., 20, 337, 1979
Stewart, D. J. 1989. Nausea and vomiting in cancer patients. In Nausea and vomiting: recent research and clinical advances. Edited by R. K. Harding, J. Kucharzyk, and D. J. Stewart. CRC Press, Inc., Boca Raton.
Stewart, D.J., Cancer therapy, vomiting and antiemetics, Canadian Journal of Physiology and Pharmacology, 2/90, 68 (2) pp 304-13.
Stuart, J., Welsh, J., Sangster, G., Scullion, M., Cash, H., Kaye, S., and Calman, K., The antiemetic potential of oral levonantradol in patients receiving cancer chemotherapy, Br. Journal Cancer, 46(3), 492, 1982
Stuart-Harris, R., Mooney, C., and Smith, 1., Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional antiemetic therapy, Clinical Oncol.,9(2), 143, 1983
Sweet, D., Miller, N., Weddington, W., Senay, E., and Sushelsky, L.,Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy—a pilot study, Journal Clinical Pharmacol., 21, 70S, 1981
Tortorice, P.V. and O’Connell, M.B., Management of chemotherapy-induced nausea and vomiting, Pharmacotherapy, 1990, 10 (2) pp 129-45.
Triozzi, P.L. and Laszlo, J., Optimum management of nausea and vomiting in cancer chemotherapy, Drugs, 7/87, 34 (1) pp 136-49.
Ungerleider, J., Andrysiak, T., Fairbanks, L., Goodnight, J., Sarna, G., and Jamison, K., Cannabis and cancer chemotherapy, a comparison of oral delta-9-THC and prochlorperazine, Cancer, 50(4), 636, 1982
Ungerleider, J., Andrysiak, T., Fairbanks, L., Tesler, A., and Parker, R., Tetrahydrocannabinol vs. prochlorperazine, the effects of two antiemetics on patients undergoing radiotherapy, Radiology, 150(2), 598, 1984
Vincent, B. J., McQuiston, D., Einhorn, L., Nagy, C., and Brames, M., Review of cannabinoids and their antiemetic effectiveness, Drugs, 25(Suppl. 1), 52, 1983
Wada, J., Bogdon, D., Gunnell, J., Hum, G., and Rieth, T., Double-blind randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy, Cancer Treat. Rev., 9 (Suppl. B), 39, 1982
Welch, D. 1981. Nutritional compromise in radiation therapy patients experiencing treatment-related emesis. Journal Parenter. Enteral Nutr. 5: 57—60
Frytak, S., Moertel, C., O’Fallon, J., Rubin, J., Creagan, E., O’Connell, M., Schutt, J., and Schwartau, N., Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy, a comparison with prochlorperazine and a placebo, Ann. Int. Medicine, 91(6), 825, 1979

As an Anticonvulsant In Seizure Disorders

No testing of whole Marijuana has been done, but various Cannabis-based molecules without “high” qualities have been shown to be very effective in some seizure models. Seizure models are attempts to set up working cause-and-effect mechanisms which explain how different seizures happen. Scientists are just beginning to figure out which pathways in the brain/body are involved in seizures, which are a very complex set of related but separate phenomena.

All this begs the issue somewhat, because it’s clear from both the clinical studies and from folk knowledge that smoking a joint can bring quality relief from many different kinds of seizures. It’s those dreaded “side-effects” again which keep the search for a High-free pharmaceutical going, and keep effective therapy out of the hands of those in need.

The use of Marijuana alternatives offers those with seizure problems the potential for all-day control of the problem, with a very manageable “High”. The manageability issue is important because many people with seizure problems are otherwise vigorous, healthy people who lead normal lives until the seizure cuts them down. If they happen to be in the middle of something dangerous like driving a car or handling a power tool, such flash incidents can be life threatening. A manageable level of Marijuana high will not interfere with many kinds of work, and will actually help make some kinds of work more enjoyable and potentially more productive.

Contrary to all the propaganda, and most disturbing to those who preach inevitable doom with the first criminal encounter with dope, there have been some very well done, beyond-reproach studies which show that a certain portion of the population actually does better at the task of driving a car when high on Marijuana than when “straight”. Almost anyone who is a regular Marijuana user will tell you the same thing. And the fact that Marijuana shows up very rarely by itself in the blood tests of traffic fatalities means that the millions of people who use Marijuana regularly and nothing else are not having fatal car crashes or doing other things that get their blood sampled.

The implication for people with seizure disorders is to consider, and talk over with your doctor the idea of training yourself to get along while being a little high all day in order to get the benefits of this natural anti-seizure medicine.

Some Useful Readings

Boyd, E. H., Boyd, E. S., and Brown, L. E., Differential effects of a tetrahydrocannabinol and pentobarbital on cerebral cortical neurons, Neuropharmacology, 14, 533, 1975
Boyd, E. S., Boyd, E. H., and Brown, L. E., The effects of some drugs on an evoked response sensitive to tetrahydrocannabinols, Journal Pharmacol. Exp. Ther., 189, 748, 1974
Calne, D. B. and Klawans, H. L., Pathophysiology and pharmacotherapy of tremor, Pharmacol. Ther.,2, 113, 1977
Carlini, E. A., Mechoulam, R., and Lander, N., Anticonvulsant activity of four oxygenated cannabidiol derivatives, Research Commun. Chem. Pathol. Pharmacol., 12, 1, 1975
Carlini, E.A. and Cunha, J.A., Hypnotic and antiepileptic effects of cannabidiol, Journal of Clinical Pharmacology, 1981: 21, pp 417S-427S
Chiu, P., Olsen, D. M., Borys, H. K., Karler, R., and Turkanis, S. A,. The influence of cannabidiol and Delta 9-tetrahydrocannabinol on cobalt epilepsy in rats, Epilepsia, 20, 365, 1979.
Colasanti, B. K., Lindamood, C., and Craig, C. R., Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats, Pharmacol. Biochem. Behav., 16, 573, 1982.
Consroe, P. and Wolkin, A., Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats, Journal Pharmacol. Exp. Ther., 201, 26, 1977
Consroe, P. F. and Man, D. P., Effects of Delta 1 and Delta 9-tetrahydrocannabinol on experimentally induced seizures, Life Sci., 13, 429, 1973
Consroe, P. F., Wood, G. C., and Buchsbaum, H., Anticonvulsant nature of marijuana smoking, JAMA, 234, 306, 1975
Consroe, P., Benedito, M. A. C., Leite, J. R., Carlini, E. A., and Mechoulam, R., Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice, Eur. Journal Pharmacol., 83, 293, 1982
Consroe, P., Jones, B., Laird, H., and Reinking, J., Anticonvulsant-convulsant effects of delta-9 tetrahydrocannabinol, in The Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R. C., Eds., Plenum Press, New York, 1976
Consroe, P., Martin, A., and Singh, V., Antiepileptic potential of cannabidiol analogs. Journal Clinical Pharmacol., 21, 428s, 1981.
Corcoran, M. E., McCaughran, J. A., and Wada, J. A., Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled rats, Epilepsia, 19, 47, 1978.
Cox, B., Tenham, M., Loskota, W. J., and Lomax, P., The anticonvulsant activity of cannabinoids in seizure sensitive gerbils, Proc. West. Pharmacol. Soc., 18, 154, 1975
Craigmill, A. L., Cannabinoids and handling-induced convulsions, Research Commun. Psychol. Psychiatr. Behav.,4, 51, 1979
Davis, J. P. and Ramsey, H. H., Antiepileptic action of marijuana-active substances, Fed. Proc., 8, 284, 1947
Delgado-Escueta, A. V., Treiman, D. M., and Walsh, C. 0., The treatable epilepsies, New Engl. Journal Medicine,308, 1576, 1983
Feeney, D. M., Marijuana and epilepsy: paradoxical anticonvulsant and convulsant effects, in Marihuana: Biological Effects, Nahas, G. G. and Paton, W. D. M., Eds., Pergamon Press, Oxford, 1979
Feeney, D. M., Marijuana use among epileptics, JAMA, 235, llOS, 1976.
Feeney, D. M., Spiker, M., and Weiss, G. K., Marihuana and epilepsy: activation of symptoms by delta-9-THC, in The Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R. C., Eds., Plenum Press, New York, 1976, 343.
Fish, B. S., Consroe, P., and Fox, R. R., Convulsant-anticonvulsant properties of delta-9-tetrahydrocannabinol in rabbits, Behav. Genet., 13, 205, 1983
Gram, L., Bentsen, K. D., Parnas, J., and Flachs, H., Controlled trials in epilepsy: a review, Epilepsia, 23, 491, 1982 .
Izquierdo, I. and Nasello, A., Effects of cannabidiol and other cannabis sativa compounds on hippocampal seizure discharges, Psychopharmacology 1973: 28, pp 95-102
Juul-Jensen, P. and Foldspang, A., Natural history of epileptic seizures, Epilepsia, 24, 297, 1983.
Karler, R. and Turkanis, S.A, The cannabinoids as potential antiepileptics, Journal of Clinical Pharmacology, 1981: 21, pp 4375-4485.
Karler, R. and Turkanis, S.A., Cannabis and epilepsy, in Marijuana: Biological Effects, ed. G. Nahas and W. Paton, Pergamon Press, Oxford, 1979, pp 619-641
Karler, R. et al, Anticonvulsant properties of Delta-9 THC and other cannabinoids, Life Sciences 1974: 15, pp 931-47.
Karler, R., Borys, H. K., and Turkanis, S. A., Influence of 22-day treatment on the anticonvulsant properties of cannabinoids, Naunyn-Schmiedeberg’s Arch. Pharmakol., 320, 105, 1982
Krall, R. L., Penry, J. K., Kupferberg, H. J., and Swinyard, E. A., Antiepileptic drug development. 1. History and a program for progress, Epilepsia, 19, 393, 1978.
Perez-Reyes, M. and Wingfield, M., Cannabidiol and electroencephalographic epileptic activity, JAMA, 230, 1635, 1974
Sofia, R. D., Solomon, T. A., and Barry, H., Anticonvulsant activity of Delta 9-tetrahydrocannabinol compared with three other drugs, Eur. Journal Pharmacol., 35, 7, 1976
Testa, R., Graziani, L., and Graziani, G., Do different anticonvulsant tests provide the same information concerning the profiles of antiepileptic activity?, Pharmacol. Research Commun., 15, 765, 1983.
Turkanis, S. A. and Karler, R., Electrophysiologic mechanisms of delta-9-tetrahydrocannabinol’s convulsant actions, in the Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, Agurell, S., Dewey, W. L., and Willette, R. E., Eds., Academic Press, New York, 1984, 845.
Turkanis, S. A. and Karler, R., Electrophysiologic properties of the cannabinoids, Journal Clinical Pharmacol., 21, 449s, 1981.
Turkanis, S. A. and Karler, R., Excitatory and depressant effects of Delta 9-tetrahydrocannabinols and cannabidiol on cortical evoked responses in the conscious rat, Psychopharmacoloey, 75, 294, 1981.
Turkanis, S. A., Chiu, P., Borys, H. K. and Karler, R., Influence of Delta 9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials, Psychopharmacology, 52, 207, 1977.
Turkanis, S. A., Smiley, K. A., Borys, H. K., Olsen, D. M., and Karler, R., An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats, Epilepsia, 20, 351, 1979
Wada, J. A., Osawa, T., and Corcoran, M. E., Effects of tetrahydrocannabinols on kindled amygdaloid seizures and photogenic seizures in Senegalese baboons, Papiopapio, Epilepsia, 16, 439,1975.
Wada, J. A., Wake, A., Sato, M., and Corcoran, M. E., Antiepileptic and prophylactic effects of tetrahydrocannabinol in amygdaloid kindled cats, Epilepsia, 16, 503, 1975
Wada, J.A. et al, Antiepileptic properties of delta-9 THC, Experimental Neurology, 1973: 39, pp 157-65
Woodbury, D. M., Application to drug evaluation, in Experimental Models of Epilepsy, Purpura, D. P., Penry, J. K., Tower, D., Woodbury, D. M., and Walter, R., Eds., Raven Press, New York, 1972, 557.

Movement Disorders

There is a long list of symptoms which the research literature identifies as yielding to Marijuana therapy:
• akinesia or bradykinesia
• ataxia
• catalepsy
• spasm, tremor
• dystonia (cramped muscles fixing limb or body in an abnormal posture/position)
• Tonic component: dystonic posture & pain
• Phasic component: dystonic spasms and tremor
• Spasticity
• Iatrogenic Dyskinesia
• Epileptic activity
• Muscle Spasms associated with Multiple Sclerosis
• Tourette Syndrome
• chorea ( in Huntington’s Disease)

Some Useful Readings

Consroe, P. et al, Open label evaluation of cannabidiol in dystonic movement disorders International Journal of Neuroscience, 11/86, 30 (4) pp 277-82.
Edmonds, H. L., Hegreberg, G. A., van Gelder, N. M., Sylvester, D. M., Clemmons, R. M., and Chatburn, C. G., Spontaneous convulsions in beagle dogs, Fed. Proc., 38, 2424, 1979
Giusti, G. V., Chiarotti, M., Passatore, M., Gentile, V., and Fiori, A., Muscular dystrophy in mice after chronic subcutaneous treatment with cannabinoids, Forensic Sci., 10, 133, 1977
Lang, A. E., Sheehy, M. P., and Marsden, C. D., Anticholinergics in adult-onset focal dystonia, Journal Can. Sci. Neurol., 9, 313, 1982.
Marsden, C. D. and Schachter, M., Assessment of extrapyramidal disorders, Br. Journal Pharmacol., ll, 129, 1981
Marsden, C. D., Treatment of torsion dystonia, in Disorders of Movement, Barbeau, A., Ed., Lippincott, New York, 1981
Meinck, H.M., et al, Effects of cannabinoids on spasticity and ataxia in multiple sclerosis, Journal of Neurology, 2/89, 236 (2) pp 120-2.
Moss, D. E., Montgomery, S. P., and Salo, A. A., Tetrahydrocannabinol effects on extrapyramidal motor behaviors in an animal model of parkinson’s disease, in The Cannabinoids: Chemical, Pharmacological and Therapeutic Aspects, Agurell, S., Dewey, W. L., and Willette, R. E., Eds., Academic Press, New York, 1984
Moss, D.E. et al, Nicotine & cannabinoids as adjuncts to neuroleptics in the treatment of Tourette Syndrome and other motor disorders,Life Science, 1989, 44 (21) pp 1521-5.
Porter, R. J., Efficacy of antiepileptic drugs, in Epilepsy, Ward, Jr., A. A., Penry, J. K., and Purpura, D., Eds., Raven Press, New York, 1983, 225.
Rosell, S., Agurell, S., and Martin, B., Effects of cannabinoids on isolated smooth muscle preparations, in Marijuana, Nahas, G. G., Ed., Springer, New York, 1976, 397
Turkanis, S. A. and Karler, R., Effects of Delta 9 tetrahydrocannabinol on cat spinal motoneurons, Brain Research, 288, 283, 1983 .
Yung, C. Y., Clinical features of movement disorders, Brain Research Bull., 11, 167, 1983

As a Muscle Relaxant in Spinal Injury

It is well known around the rehabilitation centers of this country that smoking a joint is one of the best way to relieve the cramped muscles, tics, shakes and tremors, the involuntary yawning and tortured posturing accompanying so many kinds of spinal cord injuries, brain damage, and degenerative diseases.

There are also about 250,000 people in America with Central Pain Syndrome arising from Spinal Cord Injury or certain kinds of Stroke. Central Pain, or Thalamic Pain is an unremitting whole-body torture which can’t be relieved by any of existing pain therapy, including opiate drugs. While there are several potentially revolutionary drugs on the horizon for Central Pain its victims suffer at the highest levels of physical torture and can get no relief. I have two close friends who have suffered CPS for years, both from SCI, and both have told me that without marijuana they would have committed suicide long ago. One of them has tried the smoke enema and reports remarkable relief from the pain’s intensity lasting several hours, while my other friend jokes that he’s tried to avoid having smoke blown up his ass all his life and he isn’t about to begin doing it to himself now.

Some Useful Readings

Dunn, M. and Davis, R., The perceived effects of marijuana on spinal cord injured males, Paraplegia, 12, 175, 1974
Malec, J., Harvey, R. F., and Cayner, J. J., Cannabis effect on spasticity in spinal cord injury, Arch. Phys. Medical Rehabil., 63, 116, 1982
Petro, D. J., Marihuana as a therapeutic agent for muscle spasm or spasticity, Psychosomatics, 21, 81, 1980
Petro, D.J. and Ellenberger, C.E., Treatment of human spasticity with Delta-9 THC, Journal of Clinical Pharmacology, 1981: 21, pp 413S-416S.

For Glaucoma

This is perhaps the second-best known application of Marijuana, and is an extremely well-researched field. This may be because eye problems are one of the few areas where Marijuana can be administered as a pharmaceutical preparation without “danger” of getting the patient high. While there are plenty of reasons why a person with glaucoma might want to use Marijuana to get high and treat the disease, many people would just as soon be able to do so without smoking. Marijuana administered in just about every form imaginable in just about every way possible has been tested for effectiveness in dealing with the symptoms, with good results overall.

There appears to be a lot of variability in the way different people with Glaucoma react to the use of Marijuana. Since eye pressure changes are easily and reliably measurable on an outpatient basis, and since there are so many possible factors at work, anyone with Glaucoma would be well advised to find a knowledgable medical professional to work with to discover the optimal form of Marijuana therapy. However it is also a fact that many, many people with this threatening disease self-medicate with little or no medical supervision, but in the absence of studies it’s hard to know what happens.

Some Useful Readings

Colasanti, B.K. et al, Ocular hypotension, ocular toxicity, and neurotoxicity in response to marijuana extract and cannabidiol, General Pharmacology, 1984, 15 (6) pp 479-84.
Cooler, P. and Gregg, J.M., Effect of Delta-9 THC on interocular pressure in humans, Southern Medical Journal, 1977: 70, pp 951-54.
Dawson, W. W., Jimenez-Antillon, C. F., Perez, J. M., and Zeskind, J. A., Marijuana and vision —after ten years’ use in Costa Rica, Investigations in Ophthalmology & Visual Science, 16, 689, 1977
Deutsch, H. M., Green, K., and Zalkow, L. H., Isolation of ocular hypotensive agents from Cannabis sativa, Journal Clinical Pharmacol., 21, 479S, 1981
Elsohly, M. A., Harland, E. C., Benigni, D. A., and Waller, C. W., Cannabinoids in glaucoma. ll. The effect of different cannabinoids on intraocular pressure of the rabbit, Current Eye Research, 3, 841, 1984
Elsohly, M. A., Harland, E., Murphy, J. C., Wirth, P., and Waller, C. W., Cannabinoids in glaucoma: a primary screening procedure, Journal Clinical Pharmacol., 21, 472S, 1981
Flom, M. C., Adams, A. J., and Jones, R. T., Marijuana smoking and reduced pressure in human eyes: drug action or epiphenomenon?, Investigations In Ophthalmology, 14, 52, 1975
Green, K. and Kim, K., Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system, Exp. Eye Research, 23, 443, 1976.
Green, K. and Podos, M., Antagonism of arachidonic acid induced ocular effects of Delta tetrahydrocannabinol, Investigations In Ophthalmology, 13, 422, 1974
Green, K. and Roth, M., Marijuana in the medical management of glaucoma, Perspectives In Opthamology, 1980: 4, 101-05.
Green, K. and Roth, M., Ocular effects of topical administration of Delta 9-tetrahydrocannabinol in man, Arch Ophthalmol., 100, 265, 1982
Green, K., Bigger, J. F., Kim, K., and Bowan, K., Cannabinoid penetration and chronic effects in the eye, Exp. Eye Research, 24, 197,1977
Green, K., Bigger, J. F., Kim, K., and Bowman, K., Cannabinoid action on the eye as mediated through the central nervous system and local adrenergic activity, Exp. Eye Research, 24, 189, 1977
Green, K., Symonds, C. M., Oliver, N. W. and Elijah, R. D., Intraocular pressure following systemic administration of cannabinoids, Current Eye Research 2, 247, 1982
Green, K., The ocular effects of cannabinoids, Current Topics Eye Research., 1, 175, 1979
Green, K., Wynn, H., and Bowman, K. A., A comparison of topical cannabinoids on intraocular pressure, Exp. Eye Research, 27, 239, 1978
Harvey, D., Analytical studies on marijuana, Trends Anal. Chem., 1, 66, 1981
Hepler, R. S., Frank, J. M., and Petrus, R., Ocular effects of marihuana smoking, in the Pharmacology of Marihuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1976
Jay, W. M. and Green, K., Multiple-drop study of topically applied 1% Delta 9-tetrahydrocannabinol in human eyes, Arch. Ophthalmol., 101, 591, 1983
Johnson, M. R., Melvin, L. S., and Milne, G. M., Prototype cannabinoid analgetics, prostastlandins and opiates—search for points of mechanistic action, Life Sci., 31, 1703, 1982
Korczyn, A., The ocular effects of cannabinoids, Gen. Pharmacol., 11, 419, 1980
McLaughlin, M.A. and Chiou, G.C., A synopsis of recent developments in antiglaucoma drugsJournal of Ocular Pharmacology, Spring 1985, 1(1) pp 101-21.
Merritt, J. C., Cook, C. E., and Davis, K. H., Orthostatic hypotension after Delta 9-THC marijuana inhalation, Ophthalm. Research, 14, 124, 1982
Merritt, J. C., Crawford, W. J., Alexander, P. C., Anduze, A. L., Gelbart, S. S., Effect of marihuana on intraocular and blood pressure in glaucoma, Ophthalmologv, 87, 222, 1980
Merritt, J. C., McKinnon, S., Armstrong, J. R., Hatem, G., and Reid, L. A., Oral Delta 9-tetrahydrocannabinol in heterogeneous glaucomas, Ann. Ophthalmol., 12, 947, 1980
Merritt, J. C., Olsen, J. L., Armstrong, J. R., and McKinnon, S. M., Topical Delta 9-tetrahydrocannabinol in hypertensive glaucomas, Journal Pharm. Pharmacol., 33, 40, 1981
Merritt, J. C., Perry, D. D., Russell, D. N., and Jones, B. F., Topical Delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma, Journal Clinical Pharmacol., 21, 467S, 1981
Perez-Reyes, M., Wagner, D., Wall, M. E., and Davis, K. H., Intravenous administration of cannabinoids and intraocular pressure, in the Pharmacology of Marihuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1976
Podos, S. M., Becker, B., and Kass, M. A., Prostaglandin synthesis, inhibition, and intraocular pressure, Invest. Ophthalmol., 12, 426, 1973
Razdan, R. K., Howes, J. F., and Pars, H. G., Development of orally active cannabinoids for the treatment of glaucoma, in Problems of Drug Dependence 1982, NIDA Research Monograph 43, Harris, L. S., Ed., Publ. No. (ADM) 83-1264, Department of Health and Human Services, Washington, D.C., 1983
Shapiro, D., The ocular manifestations of the cannabinols, Ophthalmologia, 168, 366, 1974
Zimmerman, T. J., Leader, B., and Kaufman, H. E., Advances in ocular pharmacology, Annual Rev. Pharmacological Toxicology, 20, 415, 1980

In Bronchial Asthma

This use of Marijuana has not been well-researched, but the few studies available seem to show that Marijuana is an effective bronchodialator, better in fact than many pharmaceuticals. Marijuana seems to be more effective than commercial pharmaceuticals for asthmatic people who have heart, thyroid, diabetic and hypertension problems, all of which are seriously aggravated by many available bronchodialator drugs.

It isn’t necessary to smoke Marijuana to obtain the bronchodialator effects. The research studies which administered Marijuana orally as an extract mist, and by swallowing a capsule filled with extract found that the method of ingestion did not affect Marijuana’s ability to arrest asthma symptoms.

Marijuana can also be a real relief for the stress and anxiety which accompany asthma attacks. Working with the high to identify and relax stressed areas of the body is something which many regular Marijuana users have been doing for years, and asthmatic people in most cases could benefit from this aspect of Marijuana as well as from the indisputably attractive bronchodialator effects.

Some Useful Readings

Abboud, R. T. and Sanders, H. D., Effect of oral administration of Delta 9-THC on airways mechanics in normal and asthmatic subjects, Chest, 70, 480, 1976
Davies, B. H., Radcliffe, S., Seaton, A., and Graham, J. D. P., A trial of oral Delta – 1 THC in reversible airways obstruction, Thorax, 30, 80, 1975
Gong, H., Tashkin, D. P., Simmons, M. S., Calvarese, B., and Shapiro, B. J., Acute and subacute bronchial effects of oral cannabinoids, Clinical Pharmacol. Ther., 35, 26-32, 1984
Graham, J. D. P., Davies, B. H., Seaton, A., and Weatherstone, R. M., Bronchodilator action of extract of cannabis and Delta 1 tetrahydrocannabinol, in The Pharmacology of Marijuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1976
Hartley, J. P. R., Nogrady, S. G., Seaton, A., and Graham, J. D. P., Bronchodilator effect of Delta 1-THC, Br. 1. Clinical Pharmacol., 5, 523, 1978
Shapiro, B. J. and Tashkin, D. P., Effects of beta adrenergic blockade and stimulation on cannabis bronchodilatation, in Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R. C., Eds., Plenum Press, New York, 1976, 173
Shapiro, B. J. and Tashkin, D. P., Effects of Beta-adrenergic blockage and muscarinic stimulation on cannabis bronchodilation, in Pharmacology of Marijuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1976, 277
Shapiro, B. J., Tashkin, D. P., and Frank, 1. M., Mechanism of increased specific airway conductance with marijuana smoking in healthy young men, Ann. Intern. Medicine, 78, 832, 1973
Shapiro, B. J., Tashkin, D. P., and Vachon, L., THC as a bronchodilator. Why bother?, Chest, 71, 558, 1977
Tashkin, D. P., Reiss, S., Shapiro, B. J., Calvarese, B., Olsen, J. L., and Lodge, J. W., Bronchial effects of aerosolized Delta 9-THC in healthy and asthmatic subjects, Am. Rev. Resp. Dis., l1S, 57, 1977
Tashkin, D. P., Shapiro, B. J., and Frank, 1. M., Acute effects of marijuana on airways dynamics in spontaneous and experimentally induced bronchial asthma, in The Pharmacology of Marijuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1976
Tashkin, D. P., Shapiro, B. J., and Frank, 1. M., Acute effects of smoked marijuana and oral Delta 9 tetrahydrocannabinol on specific airways conductance in asthmatic subjects, Am. Rev. Resp. Dis., I 09, 420, 1974
Tashkin, D. P., Shapiro, B. J., Lee, Y. E., and Harper, C. E., Effects of smoked marijuana in experimentally induced asthma, Am. Rev. Resp. Dis., 112, 337, 1975
Vachon, L. and Sulkowski, A., The effect of Beta-adrenergic blockade on acute marijuana intoxication, in The Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R., Eds., Plenum Press, New York, 1976, 161
Vachon, L., Fitzgerald, M. X., Solliday, N. H., Gould, 1. A., and Gaensler, E. A., Single dose effect of marijuana smoke, N. Engl. Journal Medicine, 288, 985, 1973
Vachon, L., Mikus, P., Morrissey, W., FitzGerald, M., and Gaensler, E., Bronchial effects of marijuana smoke in asthma, in The Pharmacology of Marijuana, Braude, M. C. and Szara, S., Eds., Raven Press, New York, 1975
Vachon, L., Robins, A. G., and Gaensler, E. A., Airways response to aerosolized Deta 9-THC: preliminary report, in The Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R. C., Eds., Plenum Press, New York, 1976
Vachon, L., Robins, A. G., and Gaensler, E. A., Airways response to micro aerosolized Delta 9-THC, Chest, 70, 444, 1976
Williams, S. J., Hartley, J. P. R., and Graham, J. D. P., Bronchodilator effect of Delta 1-THC administered by aerosol to asthmatic patients, Thorax, 31, 720, 1976

For Hypertension & Anxiety

Recent discoveries that Marijuana acts on the same receptors in the brain as many commercial tranquilizers has reinforced clinical evidence that it is a superior relaxant and anti-anxiety drug. This will come as no news to millions of people, but many of those who have most needed to get mellow over the past years have been so mesmerized by the anti-drug hysteria that they have been stuck with trying to use alcohol and cigarettes to control anxiety. With damn little success, of course, because both these drugs first appear to relieve and then re-install anxiety at higher levels. When such folks are finally floored by their accumulated stress and toxicity, Marijuana offers a pleasant, inexpensive natural alternative which will, after only a brief trial, win the hearts and minds of 99% of these poor propagandized souls.

It’s not just the booze and cigs crowd that suffers from hypertension and anxiety; almost everybody has a few pet anxieties which regularly claw their insides out, and Americans are becoming notorious in the world for the rate at which we allow stress to disable and kill us.

Some Useful Readings

Freemon, F.R., The effect of Delta-9 THC on sleep, Psychopharmacologia, 1974: 35, pp 39-44.
Sethi, B.B. et al, Antianxiety effect of Cannabis: involvement of central benzodiazepine receptors,Biological Psychology, 1/86, 21 (1) pp 3-10.
Zaugg, H. E. and Kyncl, J., New antihypertensive cannabinoids, Journal Medical Chem., 26, 214, 1983
Zuardi, A. W., Shirakawe, J., Finkelfarb, E., and Karniol, 1., Action of cannabidiol on the anxiety and other effects produced by Delta 9-THC in normal subjects, Psychopharmacology, 76, 245, 1982

For Insomnia

In line with Marijuana’s complex nature, the same flower which when consumed allows you to stay up all night with friends engaging in vigorous dialogue allows you, under different circumstances, to drift imperceptibly into a dream state from which you wake in the morning refreshed and alert.

As in so many other uses of Marijuana, set and setting are very important in effectively addressing insomnia. All the usual accoutrements to a restful night’s sleep should be in place- a secure, quality environment, reduced potential for noise or interruption, loving thoughts, and a conscious desire to approach sleep. Reading a book while high is an excellent way to drift off into your own thoughts, and doing so while in bed is a classic approach to induced sleep. Meditation tapes now generally available are also an excellent tool to use while high, especially those specifically designed to place the mind in a mood to sleep restfully.

Marijuana is not a sleeping pill; it does not knock you out to achieve its effect. Marijuana is a mind-medicine, not a body medicine even though it has profound and overwhelmingly positive body effects. In fact, it is up to you to consciously use the Marijuana, not to passively take a “big enough dose” to put you to sleep by chemically overwhelming your nervous system so it doesn’t transmit worry or discomfort signals, which is how most so-called “sleeping aids” work.

In Eating Disorders

Here is another area of medicinal benefit where it is not so much the chemical properties of Marijuana as its mental effect which is responsible for the desired action.

Marijuana is well-known among people who use it socially and recreationally for the effect called the Blind Munchies. When a person is in the grip of the munchies nothing edible within reach is safe, especially food that responds to those deep-level body hungers we call cravings. There has been speculation that blood sugar levels are involved, but the research is inconclusive. The BM’s are not predictable in the sense that they are invariably brought on by use of Marijuana.

Whatever occurs to you when you are in this state is what you want, and normal behavior can go right out the window. It doesn’t matter if that last granola bar belongs to someone else- it’s gone; it doesn’t matter that it’s only 9AM- you want a double pepperoni pizza. Otherwise normal people caught in the grips of the Blind Munchies become slightly deranged; fixated may be a better word. They do not wait calmly in line at the ice cream store, they can’t wait until they’re out of the convenience store to open their candy bar.

All this is not a pretty sight, and probably contributes to Marijuana’s bad reputation among the other kinds of folks who hang out at ice cream stores and candy counters and encounter these hulking red-eyed fiends.

Now, one might reasonably ask how such an effect could possibly help someone who is ill?
The blind munchies seem to be the result of a combination of factors, including the (perhaps unrecognized) presence of deep cravings, and the process of suggestion. These factors are the reasons why Marijuana has therapeutic potential in the area of eating disorders.

Marijuana focuses attention, and if the high person’s attention is directed in a subtle way toward the deep levels at which food/nutritional cravings exist, the body-mind will pick up those signals and can experience them as desire and intense attractiveness. Not invariably, and not always perfectly, but the more skilled the individual or others involved in the therapy the more likely it will be that the person can come to desire and enjoy that which they need from a medical perspective.

Some Useful Readings

Costa, G., and Donaldson, S. S. 1979. Effects of cancer and cancer treatment on the nutrition of the host. N . Engl . Jour. Med . 300: 1471 1474.
Hollister, L.E., Hunger and appetite after single doses of marihuana, alcohol and dextroamphetamine, Clinical Pharmacological Thera. 1971: 12, pp 44-49.
Kokal, W. A. 1985. The impact of antitumor therapy on nutrition. Cancer, 55: 273—278.
McLaughlin, C. L., Baile, C. A., and Bender, P. E., Cannabinols and feeding in sheep, Psychopharmacology, 64, 3 21, 1979

In Treating Alcoholism

It’s no real surprise that Marijuana has been shown to be effective in helping people withdraw from alcohol addiction- it gives the addict a very attractive exchange. The intoxication benefits of Marijuana are superior, the urge to violence and aggression almost nil, and the damage to health far less.

From the moralists viewpoint this may not seem like it’s doing the alcohol addict a lot of good, but from the addicts viewpoint it makes kicking alcohol a whole lot easier. The moralists and the addict have a totally different agenda, though to get any help at all these days addicts generally have to get with the moralistic chant. It’s a true testament to the sincerity of the desperation of people trapped by alcohol that they will do anything, even roll over and sing psalms for the moralists, who parade these “saved souls” before the cameras where they stand, blinking and shuffling, looking for all the world like POW’s, which of course they are, prisoners in the war waged upon them by those who force doctrine upon the weak and broken in exchange for bread and a better cell.

Some Useful Readings

Bhargava, H., Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice, Psychopharmacology, 49, 267, 1976
Carder, B., Blockage of morphine abstinence by Delta 9-THC, Science, 190, 590, 1975
Chesher, G.B. and Jackson, D.M., Quasi-morphine withdrawal symdrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol, Pharmacology and Biochemistry Review, 7/85, 23 (1) pp 13-15.
Crancer, A. et al, Comparison of the effects of marihuana and alcohol on simulated driving performance, Science, 1969: 164, pp 851-54.
Fernandes, M. and Hill, R., Morphine-cannabinoid interactions in rats and mice, Arch. Pharmacol., 19, 282, 1974
Hine, B., Friedman, E., Torrelio, M., and Gershon, S., Morphine dependent rats. Blockade of precipitated abstinence by tetrahydrocannabinol, Science, 187, 443, 1975
Hine, B., Friedman, E., Torrelio, M., and Gershon, S., Morphine-dependent rats: blockage of precipitated abstinence by THC, Science, 187, 443, 1975
Jones, R.T and Stone, G.R., Psychological studies of marijuana and alcohol in man, Psychopharmacology 1970: 18, pp 108-17.
Reeve, V.C. et al, Marijuana-alcohol driving performance study: A summary of preliminary findings, in, Proceedings of the Ninth Annual Conference on Alcohol, Drugs and Traffic Safety, 1985
Rosenberg, C. M., Gerrein, J. R., and Schnell, C., Cannabis in the treatment of alcoholism, Journal Stud. Alcohol, 39, 155, 1978
Sprague, G. L. and Craigmill, A. L., Effects of two cannabinoids upon abstinence signs in ethanol dependent mice, Pharmacol. Biochem. Behav., 9, ll, 1978

Clinical Trials with Marijuana

Almost without exception, the clinical trials of Marijuana’s effectiveness as a therapeutic agent have involved the use of an extract from the plant, or a synthetic or derivative chemical compound manufactured in the laboratory based on the natural model from the living plant.
Without exception all researchers frame their findings in the context of seeking to isolate the high from the medical benefits. None view the high as beneficial, even as a hypothesis. All studies done in the past twenty years have as an underlying, governing assumption that getting high is undesirable and has no place in therapeutic applications of the plant.

All the research buys into the official line that consciousness-altering substances are and ought to be highly regulated and unavailable to ordinary people.

None of the researchers exhibit an overt personal familiarity with the high experience but one can read behind the lines of a few studies to see that the authors were knowledgeable people communicating effectively with colleagues but being very, very careful.

Finally, none of these studies examine the therapeutic potential for the individual using the whole flower of this remarkable plant, without the intervention of self-interested doctors, hospitals, pharmaceutical companies, police, politicians, and professional bureaucrats.

A Revolution In Caring

There is a silent revolution against uncaring health care across America, and it is being led by people who discovered and used psychoactive drugs in the 1960’s & 70’s. Most of us are now in our mid-lives, and we increasingly have parents, family members and friends suffering from disease, injury, pain, accumulated stress, degenerative conditions, mystery infirmities, and the other challenges life throws at us all.

In the revolution to bring about a caring society, many of these enlightened ones are offering the relief of natural, whole Marijuana to those in need along with their services as what one friend of mine calls herself- a Companion Guide.

In other centuries and other places the intellectuals and artists of society used Marijuana to explore realms of the mind in the name of creativity and innovation. In other still more distant places and societies, healers and holy men used this gift of Shiva as a holistic medicine for the body, and meditative gate to other levels of consciousness.

In America this century Marijuana has been used primarily as a relaxant and mild euphoric; however, it has always had a strong spiritual component. There is something in the Marijuana high which resonates with the American spirit of adventure, of quest, of exploration, of frontier, of invention, and of rebellion. The Marijuana high answers all those calls in the American soul, and although our society is still burdened with those medieval drugs alcohol and tobacco and their powerful overlords, the time will come when the choice of an enlightened, caring society will be the Marijuana high or its spiritual/meditative equivalent.

Compassionate, creative, therapeutic use of Marijuana in a psychological and spiritual healing process opens new professional opportunities for many health care professionals who are personally experienced with the Marijuana high.

Why should personally enlightened professionals continue to submit to the whips of the cynics and moralists, those evil sisters, thus depriving their patients, clients, loved ones, friends and collegues of the benefits of a wholistic approach to Marijuana therapy which uses the powerful healing high, with themselves acting as compassionate Companion-Guides as well as medical professionals.

Imagine the impact on the quality of the relationship and its healing potential if all parties to the process could use the Marijuana high to get past the kinds of barriers that typically isolate those in need from those giving care.

Historians will record the callous manipulation of the ordinary people of this world by privileged classes and their institutional representatives and enforcement agencies as the root cause of the pain, suffering and destruction of human live and values which is deliberately mislabeled “the drug problem”.

The Pain problem, the Despair problem, the Racism problem, the Poverty problem, the Ignorance problem and the Exploitation problem are real names of real problems; the “Drug Problem” is not real, it is an illusion.

Meanwhile millions of deluded puppets chant “Just Say No”, at the same time most passionately chanting “Yes! Yes! Yes!” to the whispered suggestions that theirs is the holy mission of blaming and judging and punishing others, placed in their inner by a voice they perceive as the voice of God. The irony is that the very demons they fear are the source of these suggestions, because when these crusader go forth they create dangerous, destructive passions – the dark playground of these angry entities.

The relief these crusaders promise through their “programs” is a sick illusion- there are very simply no truly effective drug rehabilitation programs anywhere. There are lots of ineffective programs which occasionally have a person enrolled who is successfully rehabilitated, for which the program’s operators then claim credit and seek additional funding, but the fact is that nothing rehabilitates an individual except inner resources combined with realistic external support, and there is no support of the kind and quality needed available in our society except for those fortunate enough to be loved and cared for by an angel.

While you’re never going to see our government research it, or announce the results if the do, there is evidence that Marijuana contains substances which protect the lungs of the smoker from the tissue changes which lead to cancer in smokers of cigarettes and those exposed to industrial smoke.

This “anti-neoplastic activity” of Marijuana has been noticed and investigated during the comprehensive search of natural substances for use as cancer drugs. This property of Marijuana was not remarkable enough to qualify it as a cure for cancer (imagine the difficulties!), but was sufficiently strong for the researchers to note that there may be some connection here with the fact that research has not been able to show the kinds of cancerous effects in long-term Marijuana smokers which show up regularly in long-term cigarette smokers. The other kinds of lung damage associated with smoking, such as emphysemia, dont appear as severe in Marijuana smokers, despite the (generally poorly done) federally sponsored research trumpeted in the media as evidence of Marijuana’s dangers.

Of course there will never be zero risk in smoking anything. But the greatest danger to Marijuana smokers appears to come directly from the authorities, in two principle ways. There is the obvious danger of arrest and exposure to draconian police and judicial strategies designed to intimidate the populace, but there is a much more direct, major danger to your health. The anti-drug authorities have persisted, in spite of official bans, to spray a variety of highly toxic chemicals onto Mexican and South American Marijuana crops, some of which is rescued by the growers and sent right along to the U.S. where Marijuana users who are driven to the streets by their government are then poisoned by that same government as a penalty for violating it’s corrupt laws. This isn’t an atrocity of the magnitude of the government-cigarette industry conspiracy, but it will do to illustrate the moral degeneracy of our decaying institutions.
The network of privileged and entrenched people who run this lunatic asylum we call home are determined that we are all going to settle down and agree to be ruled by them and their designated authorities. Their tactics are no more imaginative now than they have ever been, because when dealing with the mass of people sophisticated tactics dont work. Keep it simple, stupid. It’s easy enough in a modern democracy, especially if you control the message content of the mass media, to create a constituency of fear.

The “drug problem” is an ideal constituency-maker. Americans have been pretty constantly under the grip of the moralists and the economic interests benefited by them since the earliest days of the country, and by now many people have been thoroughly indoctrinated into accepting and vigorously believing that deviant behavior must be both controlled and punished. It’s not hard to get these folks to accept that drugs are bad, especially when you can create dramatic footage on TV and point to all the human wreckage on the streets. In line with the KI.SS principle, the public sees this stuff, listens to a few politicians and “experts” and concludes yes, by golly, there really is a “drug problem”.

But there is another reason why the “drug problem” has been created, a deeper, more important reason. Certain drugs, Marijuana perhaps foremost among them, directly threaten the mechanisms by which control of society has been exercised for centuries by the privileged and entrenched interests that transcend generations in their quest for domination of others. These mechanisms depend upon certain kinds of blindness in people, a blindness that has been cultivated intensively over the years.

Are You Shocked?

You read the papers and see the headlines about the war on drugs. You read Time and US News & World Report and Readers Digest and know about the horrors of drug abuse. You go to church and hear people you respect and trust predict that drugs will be the ruin of our society.

And now your doctor or, maybe more difficult to handle, a loving relative or friend tells you that you can get relief from your suffering with Marijuana. What are you to think? You may believe that drugs are evil, that the soft drugs lead to other, more addictive drugs, that they ruin your mind, and perhaps that they are a sin.

This section is devoted to an expression of my personal social & political viewpoints. Many people will disagree with what I say here, and if you feel this way I want you to be able to use the information in the book without having to agree with my views on the role of drugs in society and other related issues and concerns.

Social and recreational use of Marijuana is a major issue in the minds of many people, but more directly threatening and frightening are the twin problems of violent and degraded situation in our inner cities, and the sickening toll among our children. Many good people sincerely believe that these problems have been created by drugs, and can be solved by control of drugs.

I call these people good because they think of themselves as good and are motivated by what they believe are good motives. Jesus of Nazareth said at his crucifixion “Forgive them Father; they know not what they do”, and most Christians believe that Jesus was asking for forgiveness on behalf of those who were killing him, and those who had caused it to be done. I believe that these last words sum up the message of his life.

If Jesus was anything of the holy man which belief, tradition and doctrine have made him, and this was the message of his life, it would not be directed at forgiving those few poor souls who were murdering him – it would be his final offering of wisdom to all who lived then and have lived since. “Forgive them Father, they know not what they do. “

This is the gift which the prophet Jesus gave us – that in his last words, out of all the things that could have been said, he chose to ask god to forgive all people for none know what they do. If we hear that message, and realize that we know not what we do, then we may begin to awaken, and see what we do, and change what we do. As it is, we know not what we do. How else is it possible to explain the misery and evil we inflict on each other throughout the world; how else to explain why power corrupts; how else to explain our isolation from each other; how else to explain the greed and lust of those who rule; how else to explain suffering in the midst of great plenty?

The so-called drug problem is a part of that misery inflicted by some people on others, since it is almost entirely the social consequences of drug use, and not drug use itself, which produces the painful, evil consequences known as the drug problem.

Leave a comment

Pure Medical Marijuana & Natural Heirloom Tobacco – A Logical Combination


I’ve visited quite a few MM clinics in Oregon and Washington and of course, like so many public venues, these clinics are “Non-Smoking” public spaces. At every one of these clinics I’ve noticed that there were ashtrays at the door, always brimming with discarded cigarette butts. So this says to me that many of the people who are using Marijuana to help them deal with medical issues are also smoking commercial cigarettes. (Duh)
Although most people, including smokers, know that “cigarettes are bad for you” and that “smoking causes all kinds of nasty diseases”, what few people understand is that virtually all commercial cigarette brands are not manufactured from pure, natural tobacco but rather from industrial materials that vast amounts of money have been spent on to make them look and smoke like what people think of as tobacco. In other words, it is not tobacco that is sickening and killing all those people. If they were smoking pure, natural tobacco few if any of them would have to pay the price that almost every commercial cigarette smoker now pays sooner or later.

I’ve written long and detailed research reports on this topic but, very understandably, few people like to read complex technical materials, so it has been a great frustration to me to try to communicate with cigarette smokers how and why they and all those around them are being poisoned, sickened, and killed so that a murderous industry can thrive.

So I won’t go on and on here either, because I respect your time and don’t want to lose any interest you may have in this subject.

So let me offer you a 30 minute video that I did in the late 1980s which does a pretty good job of laying out the basic information behind the cigarette industry’s criminal behavior – and then let me describe the amazing opportunity that this terrible situation creates for many different sectors of the Medical Marijuana sector.

So, if you have watched this video (thank you), please consider what would happen if the Medical Marijuana community, and especially the Medical Marijuana grower community, decided that we have both the means and the responsibility to grow and produce pure, natural heirloom tobacco products in addition to the high quality Cannabis already being produced for the MM patient community.

smokerWe already have a well-established market, and we have the full confidence of people in that market. If we started selling pure, natural tobacco alongside the pure, natural Cannabis that patients are now buying from us – why wouldn’t most of our patients choose the real thing over industrialized poison. Besides, anyone who enjoys smoking what they think is tobacco now will go absolutely berserk when they get a taste of true, natural tobacco. Believe me – I’ve seen it happen, and it happens every time.

I will be happy to provide growers and entrepreneurs all the information and technical support they would need to get a natural tobacco operation up and running, from choosing which heirloom varieties to grow to the curing, flavoring, processing and small-scale manufacturing of a line of natural tobacco products. This is a project that has been close to my heart for many, many years I would welcome the chance to help to make it happen.

If we act together, we can not only offer safe and effective Cannabis medication & treatment to patients, but also take a huge step toward prevention of many of the conditions and diseases that plague the lives that are being poisoned by this loathsome industry. And we can create enormous business opportunities by doing so.

I know about the business opportunities first-hand. In the early 1980s my friend and partner Robert Marion and I created the Santa Fe Natural Tobacco Company. And I developed the company’s flagship brand American Spirit. But because I was an idiot I lost the company early in its life, but quite a few friends of mine who put $500 or $1000 into SFNT company stock in those early days are now millionaires. I, unfortunately, am not.

So I know the kind of business opportunity that natural tobacco products represent, and I believe strongly that the MM movement is in prime position to create not one, but dozens of natural tobacco products businesses right alongside the MM clinics, dispensaries, and grow-houses that are now flourishing in so much of America.

Many of us in the MM movement are very concerned about the designs that we know the worldwide cigarette industry has on this rapidly growing sector. What better way to cut these criminals off at the knees than to find an effective way to take away a large portion of their customer base?

Yes, there would be obstacles. The federal government would not be a friend – it would be a very active antagonist. The cigarette industry itself controls politicians and regulators at every level of government. But hey – didn’t we just win a huge victory for both medical and recreational marijuana by going up against exactly those kinds of odds and not backing down?

We can do the same thing with natural tobacco that we did with medical marijuana, and we can not only give a lot of people the gift of a healthier lifestyle, we can also be pro-active in fighting off what we know is the coming assault on our new and – let’s admit it – still a little vulnerable MM industry by the cigarette company predators.

Finally, just to be explicit about the role that the Medical Marijuana community can and, IMO, should play in helping patients transition from smoking poisonous industrial waste to smoking pure natural heirloom tobacco, check out this list of the top ten diseases caused by smoking commercial cigarettes – and reflect on how many of these diseases Medical Marijuana is already helping patients deal with.

1. COPD (Chronic Obstructive Pulmonary Disease)
2. Cardiovascular (heart) disease
3. Cancer (lung cancer, esophagus cancer, larynx cancer, mouth cancer, throat cancer, kidney cancer, bladder cancer, pancreas cancer, stomach cancer, cancer of the pancreas, liver cancer, cancer of the penis and cervix cancer)
4. Emphysema
5. Chronic Bronchitis
6. Asthma
7. Stroke
8. Hypertension
9. Atherosclerosis (buildup of fatty substances in the arteries)
10. Impotence
Now I ask you, if Medical Marijuana professionals and entrepreneurs can not only help those who suffer from these diseases to safely and effectively treat and in the case of some of these diseases cure their illness, how much greater impact could we have if we were also instrumental in helping prevent people from getting sick in the first place?

If ever there was an opportunity to do well by doing good, this is it.

Leave a comment

Insomnia, Inflammation Of The Blood, Cannabis & Coca Leaf

The roles of Coca Leaf and Cannabis in controlling systemic (whole body) inflammatory conditions in the human body have been discussed in a number of posts on this blog, and there is a growing understanding in the medical community of the links between systemic inflammatory conditions and major diseases, including heart disease, diabetes, obesity, cancer, dementia and depression.

These are among the leading causes of death in the US and the rest of the so-called advanced civilizations, and for the most part the medical and scientific communities of these nations seem to be either just saying “Oh well, that’s what happens when you get old” or else “Hey, we have this new, expensive, dangerous drug that will give you an extra week or two of life strapped to a hospital bed and invaded by tubes.” Oh thank you medical saviors!

However, the interaction between systemic inflammation and Insomnia, or chronic sleep deprivation, has rarely been explored, and considering that systematic inflammation is a key factor in so many debilitating and fatal diseases and conditions this is an area of research that desperately needs attention.

Since there is already substantial documentation that the right strains of Cannabis are effective sleep aids, as well as safe and effective treatments for many of the diseases and conditions related to the inflammatory processes that arise as a result of chronic Insomnia, I’ll forego reciting that evidence here and concentrate on the potential of Coca Leaf as a complimentary natural medicine. The key word here is “Complimentary”; while there is much that Cannabis can do to aid the healing process, there is also much that Coca Leaf can do, and while there is some minimal overlap each has its own place in an apothecary of natural medicines.

So first, let’s take a quick look at the existing evidence that Coca Leaf is a safe and effective treatment for systemic inflammation and many its consequences.

Here are links to some of my posts that discuss the scientific and medical evidence from the 1800s that Coca Leaf can be a safe and effective treatment for the underlying systemic inflammatory conditions that drive a wide range of deadly diseases and conditions, whether these systemic inflammatory conditions arise from Insomnia or from other known causes including diet and environmental toxicity.

Coca Leaf & Chronic Low-Level Whole Body Inflammation

Coca Leaf & Congestive Heart Failure – Part One

Coca Leaf & Congestive Heart Failure – Part Two

Coca Leaf Tea – A Possible Treatment/Cure for Alzheimer’s & Dementia?

Coca Leaf & Muscular Energy

Coca Leaf As A Potential Treatment For Deadly Forms Of Fatigue

A Simple Natural Cure For Obesity – Coca Leaf Tea

Finally, for a more comprehensive view of the medical and scientific applications of Coca Leaf please consider reading my book The Coca Leaf Papers” which includes an extensive bibliography with hyperlinks to original sources of the writings by doctors, scientists, and intelligent lay persons from the 1700’s and 1800’s on virtually every aspect of the healing powers of Coca Leaf – including, by the way, its very useful role in helping people sleep when sleep is made difficult or impossible by a wide range of problems including chronic illness, chronic pain, exhaustion, and nervousness, among others.

A recent major study ( see an abstract of the study below) has just been published that followed people suffering from persistent insomnia for over 20 years and has found solid evidence that persistent lack of sleep is associated closely with many of the major killer diseases and conditions in the US and around the world. And most relevant for those of us who advocate the medical use of both Coca Leaf and Cannabis the link between insomnia and disease and death seems to be a startling level of systemic inflammation in the body – specifically in the blood.

It is especially interesting, as mentioned earlier, that Coca Leaf and Cannabis are highly complementary but only minimally overlapping in their healing properties. In other words, it isn’t a question of having to choose between these two natural medicines. For almost every medical application, current medical and scientific research on Cannabis and historical medical and scientific research on Coca Leal make it quite evident that these two natural medicines can be most effective, and offer the greatest potential for healing, when they are used together.

With regard to the Insomnia study that we’ll examine in a moment, it’s important to note also that the researchers controlled for “confounding factors” like cigarette smoking, alcohol use, sedative use, age, physical activity levels, etc. In other words, they eliminated any role that these “confounding factors” might play so that they could say with confidence that they were looking at just the effects of persistent insomnia. This means that when they point to inflammation of the blood as a major effect, they are looking just at inflammation that is being caused by insomnia and not by other factors.

However, as they also point out, “the role of systemic inflammation in such an association is unknown”. Translated that says “We know that it’s there, and that it’s being caused by persistent insomnia, but we don’t know precisely its association with death.”

I do love scientific verbal precision because in the search for truth its important not to claim you know something for a fact when all you really know is that it seems to be a fact, but you can’t prove it. In that same vein, I don’t know for a fact that Coca Leaf controls systemic inflammation and therefore heals hearts, controls diabetes, helps the body to shed obesity, perhaps helps to reverse some forms of cancer, and reduces or eliminates dementia and depression – all I can really say is that according to my interpretation of the evidence in the writings of doctors and scientists of the 1800s, it sure looks like it could. And of course, increasingly, the healing powers of Cannabis are now being documented, and it seems like every week brings new evidence for increased efficacy in existing applications for Cannabis and findings that support new applications as well.

And it would be so damn simple to investigate and document the efficacy and safety of Coca Leaf, confirming what is still only hints and bits of historical evidence from the 1800’s, so that people could finally see that BOTH Coca Leaf and Cannabis deserve a place in the hands of people suffering from literally dozens of serious, life-threatening and life-ending diseases. We’re not talking about huge, expensive studies here, nor about massive government programs, nor about regiments of over-priced consultants, nor about the participation of Pig Pharma control freaks.

We’re talking about a few simple studies under controlled conditions among groups of people who suffer from each of these conditions using simple infusions of pure, natural Coca Leaf in the form of tea or tonic. The Coca Leaf studies probably would not be done in the US – at least at first they would have to be done in Peru, Bolivia and Uruguay, because these are the only countries in the world where enlightenment has illuminated the human mind on the subject of Coca Leaf as a natural healing medicine. Once these studies were done and published however, I can’t imagine that people in the US and Europe would allow their governments’ “War on Drugs” to continue to keep Coca leaf from assuming its rightful place in the pharmacy of natural medicines alongside Cannabis. And at the same time, since Cannabis is illegal even in countries that recognize the legitimacy of Coca Leaf, the same complimentary political, scientific and medical processes would have to take place there also.

However, there is another possibility that needs to be discussed and examined. There are many countries in the world where Cannabis is now legal, but where Coca Leaf is not. If people in any of those countries recognized the good common sense of having both Cannabis and Coca Leaf available to treat disease then it would be no problem to begin Coca cultivation in those countries.

For one thing, as pointed out in a recent post, Coca species are already widely distributed around the world, but of course only a few are really suitable as potent medicinal plants. Nevertheless, where one species of Coca flourishes as an indigenous species, the more useful spcies could also be brought into cultivation either in a natural or artificial environment.

In the 1800s Coca was widely cultivated around the world, and with modern growing technology even in those countries where Coca might not grow well in the natural outdoors environment it could easily be cultivated under indoor growing conditions. There is a vast literature available from the 1800’s on experiments that were conducted on growing Coca across the planet under a wide range of conditions. In fact one of the most successful indoor growing projects was that of Angelo Mariani, inventor of the then-famous “Vin Mariani”, whose conservatory greenhouse in the center of Paris was one of the wonders of the botanical world.

In one of my recent posts I discuss how this Journey To Healing could be organized as an ongoing project that would enable groups of people suffering from the same diseases to travel to Peru, Bolivia and/or Uruguay to be treated with not just Coca Leaf but with the whole range of Andean ethnopharamacological resources – and in the case of Uruguay patients who are already on Cannabis treatments would not have to be concerned about legal issues as they would have to be in both Peru and Bolivia, at this time.

When this happens, and when medical and scientific researchers can begin studying and documenting the healing powers of both natural medicines, as well as individual people taking the initiative into their own hands even before the formal studies have been done, perhaps then at last millions of people who now are victimized by the medical industry, Pig Pharma and Pig Government will be able to break free and heal themselves.

Let’s work together to make that day come as soon as possible.

So here’s of the Insomnia study I referred to earlier. If you want to read the full paper Elsevier will be happy to charge you an obscene amount for access, but personally I have never, and will never, pay those ripoff artists a penny for access to their chattel.

“Persistent Insomnia Is Associated With Mortality Risk”
(By) Sairam Parthasarathy, M.D. et al, published online Oct. 14, 2014 in the “American Journal of Medicine”.


Insomnia has been associated with mortality risk, but whether this association is different in subjects with persistent versus intermittent insomnia is unclear. Additionally, the role of systemic inflammation in such an association is unknown.

We used data from a community-based cohort to determine whether persistent or intermittent insomnia, defined based on persistence of symptoms over a six-year period, were associated with death during the following 20-years of follow-up. We also determined whether changes in serum C-reactive protein (CRP) levels measured over two decades between study initiation and insomnia determination were different for the persistent, intermittent, and never insomnia groups. The results were adjusted for confounders such as age, sex, body mass index, smoking, physical activity, alcohol and sedatives.

Of the 1409 adult participants, 249 (18%) had intermittent and 128 (9%) had persistent insomnia. During a 20-year follow-up period, 318 participants died (118 due to cardiopulmonary disease). In adjusted Cox proportional-hazards models, participants with persistent insomnia (adjusted Hazards Ratio [HR] 1.58, 95%CI: 1.02-2.45) but not intermittent insomnia (HR 1.22, 0.86-1.74), were more likely to die than participants without insomnia. Serum CRP levels were higher and increased at a steeper rate in subjects with persistent insomnia as compared with intermittent (p=0.04) or never (p=0.004) insomnia. Although CRP levels were themselves associated with increased mortality (adjHR: 1.36, 1.01-1.82, p=0.04), adjustment for CRP levels did not notably change the association between persistent insomnia and mortality.

In a population-based cohort, persistent, and not intermittent, insomnia was associated with increased risk for all-cause and cardiopulmonary mortality and was associated with a steeper increase in inflammation.

End of abstract

So there you have it. A well crafted longitudinal study that unequivocally makes the point that anything that prevents you from getting a good nights sleep on a regular basis is moving you swiftly toward an early grave. And all it would take to head off this morbid end of life would be a nice pipe of Cannabis at bedtime and a nice cup of Coca Leaf tea upon rising. Sounds entirely too simple, too unprofitable, and too straightforward to be worth the attention of all those important people in boardrooms and government offices worldwide, doesn’t it.

Or maybe they have a different agenda. But the marvelous thing is – they are insomniacs too. So whatever their agenda, they are as much victims as those who they are intent on victimizing. The planet is tight.


Coca Leaf, Cannabis, Consumption, Pneumonia & HIV/AIDS

This post explores a topic not frequently discussed – like not at all.

Cannabis and Coca together will be a far more effective natural therapy than either by themselves, no matter how powerful they each are individually.

One of the most effective applications of Medical Cannabis is to relieve the suffering from a set of core symptoms associated with HIV/AIDS. The primary HIV/AIDS symptoms that yield to Cannabis therapy are anxiety, appetite loss and nausea. Relief from appetite loss and nausea are especially critical because of the muscle, organ and tissue wasting caused by the disease and the accompanying loss of energy to fight the disease.

NORML points out that survey data indicates that “Cannabis is used by as many as one in three North American patients with HIV/AIDS to treat symptoms of the disease as well as the side-effects of various anti-retroviral medications. One recent study reported that more than 60 percent of HIV/AIDS patients self-identify as “medical cannabis users,” and at least one study has reported that patients who use cannabis therapeutically are 3.3 times more likely to adhere to their anti-retroviral therapy regimens than non-cannabis users.”

My main speculation about the Cannabis/Coca relationship is that by combining Cannabis Flower to increase appetite and Coca Leaf to increase metabolism people would have a 100% natural, user-friendly approach to restoring nutritional balance if they were battling the wasting effects of HIV/AIDS.

I’ve also been looking at the signs and symptoms of HIV/AIDS and its accompanying opportunistic infections, and at what the scientific and medical literature from the 1800’s can tell us about the role that Coca Leaf might play alongside Cannabis.

While there was no HIV/AIDS in the 1800’s I have been studying the use of Coca Leaf to relieve and treat multiple symptoms of several diseases with symptoms that either are, or seem to be the same as major symptoms of HIV/AIDS – especially Consumption, as it was called in the 1800’s, or Tuberculosis as we know it today, as well as that ages-old killer Pneumonia. And, of course, TB and Pneumonia are two of the opportunistic diseases that plague late-stage HIV/AIDS patients, so the connection here is strong.

Potentially Coca Leaf Treatable Symptoms In HIV/AIDS Primary or Acute Infection Stage

Muscle aches
Sore throat
Joint pain

Coca Leaf Treatable In HIV/AIDS Early Symptomatic Infection Stage

Weight loss
Shortness of breath

Potentially Coca Leaf Treatable Signs & Symptoms Of Principal Opportunistic HIV/AIDS Infections

Soaking night sweats
Shaking chills or fever higher than 100 F (38 C) for several weeks
Shortness of breath
Chronic diarrhea
Persistent, unexplained fatigue
Blurred and distorted vision
Weight loss

Discussion Of The Possibilities.

Skepticism is always the best approach to claims and assertions that appear to go way beyond what has already been established, so with my own skeptical hat on let’s take a look at these possibilities one-by-one.

Coca & Consumption

Let’s begin with arguably the most startling treatment concept – the potential of Coca Leaf in the treatment of Tuberculosis – known as Consumption in the 1800’s. And remember, we’re looking at a “treatment” for the nasty symptoms of TB – not a cure for disease itself. Although, of course, with proper ‘treatment’ that restored the body’s ability to fight off the disease many people in the 1800’s did manage to recover – in other words, they were cured. This is where I believe Coca Leaf therapy has much to offer – in assisting the body to re-gain its lost ability to fight off the debilitating symptoms of the disease, enabling the person to rally their inherent strength to fight more effectively.

It’s also worth remembering that in the 1800s doctors had no idea that TB was caused by a bacterium, and there were no antibiotics available to treat the disease. You may be aware of some of the approaches commonly used by doctors of that era – move the patient to a high, dry climate, or send them to a “sanitarium” for a wide range of therapies including steam baths, hot towel wraps, special diets, etc. And in some cases these treatments works – the person’s body was able to fight off TB and cure itself. Again, I believe that may be the highest role for Coca leaf – helping the person fight off some of these opportunistic infections while the anti-retroviral medications do their work.

Consumption was almost universally treated as an inflammatory disease of the lungs, which made Coca Leaf an excellent choice as part of therapy due to its well-established anti-inflammatory properties as well as its property of enabling the lungs to function efficiently at high altitudes.

Today of course we do have a wide range of medicines including specialized antibiotics to fight the disease itself and a wide range of pharmaceuticals from the magic labs of Pig Pharma to treat the symptoms of TB. All of these ‘treatments” are, naturally, virtually unaffordable and are also of doubtful benefit, but at least they give the illusion that something is being done. And of course these ‘treatments’ also give the doctors and hospitals plenty of opportunities to zoom in and out, charging you hundreds of dollars for each drive-by they conduct.

So with that noted, the question arises in my mind – is there enough evidence from the 1800’s regarding Coca Leaf and Consumption for patients and physicians today to be hopeful that Coca can be a useful part of the treatment of tuberculosis accompanying HIV/AIDS?

The simple answer is that the evidence is interesting, promising, but hardly overwhelming. In spite of the well-known anti-inflammatory properties of Coca Leaf, very few physicians in the 1800’s whose focus was the treatment of consumption appear to have taken advantage of this property of Coca Leaf in treating consumption. One of the few doctors who recorded their use of Coca in treating Consumption was the American MD William Tibbles. I’ll leave it to the reader to decide whether or not these few references merit further consideration.

(Excerpt from) “ Erythroxylon Coca: A Treatise On Brain Exhaustion As The Cause Of Disease”, By William Tibbles, MD (1877)

Case 3. A young man, age 36, was brought to me evidently suffering from pulmonary consumption, in an advanced stage; he had been given up by several eminent physicians as incurable. The symptoms under which this gentleman was suffering, were – in short – the following: a very distressing cough, pains in breast and side, expectoration of large quantities of phlegm; bowels very much relaxed; excessive night sweats; falling off of hair; paleness of countenance, with occasional hectic flush; did not keep his bed because cough was worse when in a reclining position, but unable to walk a distance of 100 yards. Pulse 126 per minute. Ascribed his complaint as a consequence of long continued sexual excesses.

We commenced treatment of this case by giving a mixture according to the following formula

Rp. Syrup of Hypophosphite of Iron
Syrup of Hypophosphite of Soda
Syrup of Hypophosphite of Lime
Each 3 ounces.
Glycerine extract of Coca-leaf, 3 ounces, mix.
Dose : two teaspoonsful three times a day. And also ordered one of my chest pills to be taken three times a day.

This treatment was continued for a period of six weeks; at the end of that time the improvement in the condition of the patient was remarkable. The night sweats had entirely disappeared; cough and expectoration greatly diminished; appetite improved; and had increased about twelve pounds in weight, and was able to walk with comparative ease a distance of two or three miles. In order to test whether this decided improvement was really due to the presence of the preparation of coca-leaf in the mixture. I determined to give him two teaspoonful doses of the mixed syrups alone, this was continued for four weeks, when I found that the patient had sunk very low again, the cough was again becoming distressing, expectoration increased, with night sweats; and he had lost nearly six pounds in weight.

This deciding the point which was raised in my mind as to whether the improvement was due to the syrups or the coca-leaf. I again gave the syrups with the coca-leaf extract, when improvement in the course of a few weeks again became decidedly apparent and proceeded.

Now to the question as to how and in what manner coca-leaf accomplishes the results which are consequent upon its use. It has been shown that all the various processes are under the influence and governance of the force conveyed through the medium of the brain, spinal cord, and their continuations – the nerves. Such being the case we may justly infer that Erythroxylon Coca influences the various functions by its action upon the great centres of the body; for it is only through these that a restorative action can be induced.

What I here want to show is that Coca-Leaf produces these results by imparting nerve food which is converted into nervous energy and thus increasing the total amount of nervous energy and consequent governing force. The functions of the nerves are only restored, when they have become exhausted by physical or mental toil or disease, till after rest etc., proportioned to the amount of exhaustion. And if it can be shown, as we have done, that coca-leaf is capable of either retarding or preventing the condition of exhaustion, and likewise of restoring an actually exhausted body; and if this can only be done by restoring the natural or normal condition of the brain and nervous system, then, we may fairly conclude that the results proved to be consequent upon the use of Erythroxylon coca are brought about simply and only by its imparting to that centre and diverging branches an amount of force which otherwise might only be obtained after partaking of rest and other things proportioned to the exhaustion.

The Coca Leaf: To The Editor Of The Standard.

Sir, – It was with great pleasure that I read an article in the Standard of March 10th upon the remarkable properties of Erythroxylon coca. I am pleased to know that scientific investigators are examining these properties. There is no doubt the public will be grateful for any information that can be given respecting the efficacy of coca in prolonged exertion and in the curing of disease. I have used coca in my practice (in this country) for nearly five years. I think it is an admitted fact that the South American Indians are the most active race of people in the world. This activity is attributed to the natives making frequent use of the leaves of the coca shrub, which grows to the height of about eight feet. Its leaves are from one inch to one inch and a half long, and are of a dark green colour; flowers white; berries red. It is carefully cultivated, and arrives at perfection in about two years, when the native Indians gather the leaves and very care- fully dry them and wrap them in palm leaves and flannel. The physiological effects of the coca leaves upon the system are evidenced by its producing a high grade of vitality (physical and mental); eyes and countenance very brisk and animated; strong pulse; a great desire for activity; the body is extremely vigorous.

I have seen no authenticated account of the coca eater dying in a wretched state; but, on the contrary, evidence goes to show that the coca eater lives to an advanced age. Two or three cases of cure from my note-book may be of interest to your readers.

Case 1. In 1873 I was called to see a gentleman, well built, aged 40 years, who, when in health weighed nearly 15 stones; but at the time I was consulted he weighed eleven stones. He was suffering from all the characteristic symptoms of consumption. His former medical attendant used the ordinary remedies without avail. Debility was so great that it was with difficulty he could walk across his room. We commenced treatment by giving him coca, which speedily relieved him, and wrought a cure in about nine weeks.

Case 2. In the same year a gentleman, aged 46 years, who had suffered for twelve years from amaurosis and paralysis of the lower extremities. In this case a mixture was given with coca, as the active ingredient, with the result that within fifteen weeks his vision was perfectly restored and he was able to walk a distance of several miles without difficulty or fatigue.

Case 3. In 1875, a lady aged 78 years was suffering from extreme debility with sickness, faintness, loss of memory, and fretfulness; her friends expected every hour her decease, but, to the surprise and wonder of her friends, after a month’s treatment with coca she was restored to her usual health and activity.

I have, with success, treated hundreds of cases of debility and consumption, of which the above are examples. In some cases I have used “cocaine”, the active principle of Erythroxylon coca. I can fully endorse the statements of the scientific gentle- men quoted in your article in respect to the efficacy of coca in prolonged exertion.

I am yours, &c, “WILLIAM TIBBLES, M.D. (U.S.)

Coca & Pneumonia

In the 1800s Coca Leaf was used to fight all kinds of respiratory disease, from persistent coughing to severe lung congestion and the accompanying inflammation – in other words, Pneumonia. If Coca Leaf proves to be as effective in fighting Pneumonia as the doctors of the 1800s said it is, then not only HIV/AIDS patients can benefit but so can hospitalized elderly people who succumb to Pneumonia as often as they do from the condition of disease that puts them in the hospital in the first place.

Here is a sampling of what doctors in the 1800s knew about Coca and Pneumonia.

(Excerpt from) “Coca Erythroxylon – It’s Uses In The Treatment Of Disease” by Angelo Mariani (1885)

“Dr. Schwalk relates a very characteristic case of pneumonia, cured by infusion of Coca, and adds: “From the experience I myself made later, in many cases of primitive acute pneumonia, as well as in cases of consecutive pneumonia, it is my opinion that Coca merits the praises which historians of Peru have given it for centuries. This wonderful plant appeases hunger and thirst, and diminishes the necessity of sleep. It is, in a word, the most powerful restorer of the vital forces. It is destined to occupy a high position in the cure of diseases of the digestive and respiratory tracts.”

“Dr. Ch. Gazeau (“Thése pour le Doctorat” Paris, 1870. Parent, édit, page 61 et seq.) thus sums up the physiological action of Coca: “On the stomach, slight excitation, anaesthesia, and probably an increase of the secretion of gastric juice; on the intestines, an increase of intestinal secretion, etc. These manifold physiological effects upon the digestive tube unite to produce a specific action, so to say, against the numerous functional troubles, so varied and so little known, of the organ; which compose it.”

“This author cites a great number of clinical observations, in which Coca has “never failed to produce an admirable action, sometimes even marvellous.” He concludes (page 65): “It seems to me useless to present other facts; these suffice to legitimize this very generalized conclusion : Coca is THE medicament PAR EXCELLENCE FOR MALADIES OF THE DIGESTIVE TRACT.”

“Prof. O. Reviel terminates his article on Coca by saying: “Much still remains to complete the physiological and clinical study of Coca. It is known that it acts upon the sensory and motor nerves. This substance will some day have an important position in therapeutics.”

Beyond Consumption & Pneumonia – Other Potential Uses Of Coca Leaf To Treat and Relieve HIV/AIDS Symptoms

You’ll notice in the lists from the Mayo Clinic that I showed earlier in this post that there is a little cluster of signs and symptoms that have to do with loss of body mass and energy. These include weight loss, wasting syndrome, and muscle and joint aches. Since I’ve covered the evidence on the role of Coca Leaf in dealing with symptoms like these I won’t repeat myself here. Just check out:

Coca Leaf & Metabolic Fire

Next we come to a biggie – persistent, chronic, overwhelming fatigue. This condition is present at every stage of HIV/AIDS and relief and prevention of fatigue is also one of the most well-established properties of Coca Leaf therapy. Again, this has already been covered here on panaceachronicles in the following posts.

Coca Leaf & Muscular Energy

Coca Leaf As A Potential Treatment For Deadly Forms Of Fatigue

Another symptom that is common at all levels of HIV/AIDS is headache, and treatment of headaches, including migraines all the way up to the phenomenon called “Exploding Brain” is one of the well-established medical applications of Coca Leaf. Treatment of the blurred and distorted vision that accompanies headaches is also well documented. Check out:

Coca Leaf, Hyper-Migraines, And The American Way of Life

Another cluster of symptoms lies around respiratory issues – shortness of breath and a persistent cough. Check the evidence for the effectiveness of Coca Leaf therapy in these posts –

Coca Leaf As A Safe, Effective Treatment For Asthma

A final group of symptoms can be classified under the heading of “inflammatory conditions” including heart failure, joint pain and muscle aches. Check the following post and see if you think that Coca Leaf therapy might be appropriate for these symptoms of HIV/AIDS

Coca Leaf & Chronic Whole Body Inflammation

Coca Leaf & Congestive Heart Failure – Part One

Coca Leaf & Congestive Heart Failure – Part Two

In Conclusion

The entire premise of this panaceachronicles blog is that now that so many courageous people have successfully fought the forces of ignorance, greed and oppression to liberate Cannabis to play its rightful role as both a powerful natural medicine as well as a superior element in experiencing a higher quality of life, it is time to do the same for Erythroxylon Coca (and for Papaver Somniferum).

I have a vision of every Citizen of the World having the right to grow their own Cannabis, Coca and Poppy plants whether in a small home garden or even indoors in pots. If I am an elderly person with aching joints, a little ball of freshly harvested opium scraped from a few of my poppies would be just the thing. If I am really tired in the morning and need to get my brain up to speed, it would be great to pick a couple of Coca leaves and make myself a cup of tea. And if I was feeling a bit low and needed some creative inspiration, why shouldn’t I be able to put a pinch of my homegrown bud in a pipe or vaporizer and get that creative boost?

This vision has nothing to do with making big bucks, wielding political and bureaucratic power, public health issues, keeping kids safe, stopping junkie crime, enforcing religious and moral codes, or any of the other tools of repression that have been used for so long to prevent regular people from growing a few simple plants that can help them in ways that no government, no political system, no institution, no organized religion, and no legal system can accomplish.

I believe that the name of this unusual concept is freedom.